The	O
promoter	B-DNA
of	O
the	O
CD19	B-DNA
gene	I-DNA
is	O
a	O
target	O
for	O
the	O
B-cell-specific	B-protein
transcription	I-protein
factor	I-protein
BSAP	B-protein
.	O

The	O
CD19	B-protein
protein	I-protein
is	O
expressed	O
on	O
the	O
surface	O
of	O
all	O
B-lymphoid	B-cell_type
cells	I-cell_type
with	O
the	O
exception	O
of	O
terminally	B-cell_type
differentiated	I-cell_type
plasma	I-cell_type
cells	I-cell_type
and	O
has	O
been	O
implicated	O
as	O
a	O
signal-transducing	O
receptor	O
in	O
the	O
control	O
of	O
proliferation	O
and	O
differentiation	O
.	O

Here	O
we	O
demonstrate	O
complete	O
correlation	O
between	O
the	O
expression	O
pattern	O
of	O
the	O
CD19	B-DNA
gene	I-DNA
and	O
the	O
B-cell-specific	B-protein
transcription	I-protein
factor	I-protein
BSAP	B-protein
in	O
a	O
large	O
panel	O
of	O
B-lymphoid	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

The	O
human	B-DNA
CD19	I-DNA
gene	I-DNA
has	O
been	O
cloned	O
,	O
and	O
several	O
BSAP-binding	B-DNA
sites	I-DNA
have	O
been	O
mapped	O
by	O
in	O
vitro	O
protein-DNA	O
binding	O
studies	O
.	O

In	O
particular	O
,	O
a	O
high-affinity	B-DNA
BSAP-binding	I-DNA
site	I-DNA
instead	O
of	O
a	O
TATA	B-DNA
sequence	I-DNA
is	O
located	O
in	O
the	O
-30	B-DNA
promoter	I-DNA
region	I-DNA
upstream	O
of	O
a	O
cluster	O
of	O
heterogeneous	O
transcription	O
start	O
sites	O
.	O

Moreover	O
,	O
this	O
site	O
is	O
occupied	O
by	O
BSAP	B-protein
in	O
vivo	O
in	O
a	O
CD19-expressing	B-cell_line
B-cell	I-cell_line
line	I-cell_line
but	O
not	O
in	O
plasma	B-cell_type
or	O
HeLa	B-cell_line
cells	I-cell_line
.	O

This	O
high-affinity	B-DNA
site	I-DNA
has	O
been	O
conserved	O
in	O
the	O
promoters	B-DNA
of	O
both	O
human	B-DNA
and	I-DNA
mouse	I-DNA
CD19	I-DNA
genes	I-DNA
and	O
was	O
furthermore	O
shown	O
to	O
confer	O
B-cell	O
specificity	O
to	O
a	O
beta-globin	O
reporter	O
gene	O
in	O
transient	O
transfection	O
experiments	O
.	O

In	O
addition	O
,	O
BSAP	B-protein
was	O
found	O
to	O
be	O
the	O
only	O
abundant	O
DNA-binding	O
activity	O
of	O
B-cell	O
nuclear	O
extracts	O
that	O
interacts	O
with	O
the	O
CD19	B-DNA
promoter	I-DNA
.	O

Together	O
,	O
this	O
evidence	O
strongly	O
implicates	O
BSAP	B-protein
in	O
the	O
regulation	O
of	O
the	O
CD19	B-DNA
gene	I-DNA
.	O

MoLEcULAR	NULL
anp	NULL
CELLULAR	NULL
BroLrooyv	NULL
,	NULL
June	NULL
1992	NULL
,	NULL
p.	NULL
2662-2672	NULL
0270-7306/92/062662-11	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1992	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

12	NULL
,	NULL
No	NULL
.	NULL

6	NULL
The	NULL
Promoter	NULL
of	NULL
the	NULL
CD19	NULL
Gene	NULL
Is	NULL
a	NULL
Target	NULL
for	NULL
the	NULL
B-Cell-Specific	NULL
Transcription	NULL
Factor	NULL
BSAP	NULL
ZBYNEK	NULL
KOZMIK	NULL
,	NULL
SHIRLEY	NULL
WANG	NULL
,	NULL
PETRA	NULL
DORFLER	NULL
,	NULL
BEN	NULL
ADAMS	NULL
,	NULL
``	NULL
anp	NULL
MEINRAD	NULL
BUSSLINGER*	NULL
Institute	NULL
of	NULL
Molecular	NULL
Pathology	NULL
,	NULL
Dr.	NULL
Bohr-Gasse	NULL
7	NULL
,	NULL
A-1030	NULL
Vienna	NULL
,	NULL
Austria	NULL
Received	NULL
5	NULL
December	NULL
1991/Accepted	NULL
4	NULL
March	NULL
1992	NULL
The	NULL
CD19	NULL
protein	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
all	NULL
B-lymphoid	NULL
cells	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
terminally	NULL
differentiated	NULL
plasma	NULL
cells	NULL
and	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
a	NULL
signal-transducing	NULL
receptor	NULL
in	NULL
the	NULL
control	NULL
of	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
complete	NULL
correlation	NULL
between	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
and	NULL
the	NULL
B-cell-specific	NULL
transcription	NULL
factor	NULL
BSAP	NULL
in	NULL
a	NULL
large	NULL
panel	NULL
of	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
human	NULL
CD19	NULL
gene	NULL
has	NULL
been	NULL
cloned	NULL
,	NULL
and	NULL
several	NULL
BSAP-binding	NULL
sites	NULL
have	NULL
been	NULL
mapped	NULL
by	NULL
in	NULL
vitro	NULL
protein-DNA	NULL
binding	NULL
studies	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
a	NULL
high-affinity	NULL
BSAP-binding	NULL
site	NULL
instead	NULL
of	NULL
a	NULL
TATA	NULL
sequence	NULL
is	NULL
located	NULL
in	NULL
the	NULL
-30	NULL
promoter	NULL
region	NULL
upstream	NULL
of	NULL
a	NULL
cluster	NULL
of	NULL
heterogeneous	NULL
transcription	NULL
start	NULL
sites	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
site	NULL
is	NULL
occupied	NULL
by	NULL
BSAP	NULL
in	NULL
vivo	NULL
in	NULL
a	NULL
CD19-expressing	NULL
B-cell	NULL
line	NULL
but	NULL
not	NULL
in	NULL
plasma	NULL
or	NULL
HeLa	NULL
cells	NULL
.	NULL

This	NULL
high-affinity	NULL
site	NULL
has	NULL
been	NULL
conserved	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
CD19	NULL
genes	NULL
and	NULL
was	NULL
furthermore	NULL
shown	NULL
to	NULL
confer	NULL
B-cell	NULL
specificity	NULL
to	NULL
a	NULL
B-globin	NULL
reporter	NULL
gene	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
BSAP	NULL
was	NULL
found	NULL
to	NULL
be	NULL
the	NULL
only	NULL
abundant	NULL
DNA-binding	NULL
activity	NULL
of	NULL
B-cell	NULL
nuclear	NULL
extracts	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
CD19	NULL
promoter	NULL
.	NULL

Together	NULL
,	NULL
this	NULL
evidence	NULL
strongly	NULL
implicates	NULL
BSAP	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
.	NULL

The	NULL
differentiation	NULL
of	NULL
B	NULL
lymphocytes	NULL
from	NULL
progenitor	NULL
cells	NULL
to	NULL
immunoglobulin-secreting	NULL
plasma	NULL
cells	NULL
is	NULL
a	NULL
multistep	NULL
process	NULL
which	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
sequential	NULL
expression	NULL
of	NULL
specific	NULL
cell	NULL
surface	NULL
markers	NULL
involved	NULL
in	NULL
cell-cell	NULL
interaction	NULL
and	NULL
signal	NULL
transduction	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Among	NULL
them	NULL
is	NULL
the	NULL
B-cell-specific	NULL
antigen	NULL
CD19	NULL
.	NULL

This	NULL
protein	NULL
is	NULL
expressed	NULL
throughout	NULL
B-cell	NULL
ontogeny	NULL
from	NULL
the	NULL
early	NULL
progenitor	NULL
cell	NULL
up	NULL
to	NULL
the	NULL
mature	NULL
B-cell	NULL
stage	NULL
and	NULL
is	NULL
lost	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
only	NULL
at	NULL
the	NULL
terminal	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

The	NULL
CD19	NULL
molecule	NULL
is	NULL
present	NULL
on	NULL
both	NULL
normal	NULL
and	NULL
malignant	NULL
B-lymphoid	NULL
cells	NULL
and	NULL
hence	NULL
is	NULL
the	NULL
most	NULL
reliable	NULL
diagnostic	NULL
surface	NULL
marker	NULL
of	NULL
the	NULL
human	NULL
B-cell	NULL
lineage	NULL
(	NULL
23	NULL
,	NULL
35	NULL
)	NULL
.	NULL

The	NULL
CD19	NULL
gene	NULL
codes	NULL
for	NULL
a	NULL
95-kDa	NULL
protein	NULL
with	NULL
two	NULL
extracellular	NULL
immunoglobulin-like	NULL
domains	NULL
,	NULL
a	NULL
short	NULL
transmembrane	NULL
region	NULL
,	NULL
and	NULL
a	NULL
large	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
33	NULL
,	NULL
34	NULL
,	NULL
38	NULL
)	NULL
.	NULL

These	NULL
features	NULL
suggest	NULL
that	NULL
the	NULL
CD19	NULL
protein	NULL
is	NULL
a	NULL
membrane	NULL
receptor	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

No	NULL
natural	NULL
ligand	NULL
for	NULL
CD19	NULL
is	NULL
as	NULL
yet	NULL
known	NULL
;	NULL
instead	NULL
,	NULL
monoclonal	NULL
anti-CD19	NULL
antibodies	NULL
have	NULL
been	NULL
used	NULL
to	NULL
study	NULL
the	NULL
physiological	NULL
function	NULL
of	NULL
the	NULL
CD19	NULL
molecule	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
receptor	NULL
hypothesis	NULL
,	NULL
antibody	NULL
binding	NULL
leads	NULL
to	NULL
rapid	NULL
internalization	NULL
of	NULL
CD19	NULL
(	NULL
7	NULL
,	NULL
35	NULL
)	NULL
and	NULL
to	NULL
mobilization	NULL
of	NULL
free	NULL
intracellular	NULL
calcium	NULL
ions	NULL
(	NULL
17	NULL
,	NULL
27	NULL
,	NULL
35	NULL
)	NULL
.	NULL

CD19	NULL
antibodies	NULL
strongly	NULL
inhibit	NULL
proliferation	NULL
of	NULL
resting	NULL
mature	NULL
B	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
with	NULL
anti-immunoglobulin	NULL
M	NULL
(	NULL
IgM	NULL
)	NULL
antibodies	NULL
(	NULL
11	NULL
,	NULL
27	NULL
,	NULL
35	NULL
)	NULL
.	NULL

They	NULL
provide	NULL
,	NULL
however	NULL
,	NULL
a	NULL
positive	NULL
proliferative	NULL
signal	NULL
for	NULL
early	NULL
precursor	NULL
B	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
CD19	NULL
is	NULL
involved	NULL
in	NULL
positive	NULL
or	NULL
negative	NULL
control	NULL
of	NULL
proliferation	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
stage	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Transmembrane	NULL
signaling	NULL
via	NULL
the	NULL
CD19	NULL
receptor	NULL
is	NULL
also	NULL
important	NULL
for	NULL
late	NULL
events	NULL
of	NULL
B-cell	NULL
differentiation	NULL
,	NULL
as	NULL
CD19	NULL
antibodies	NULL
block	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
mature	NULL
B	NULL
cells	NULL
to	NULL
plasma	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
11	NULL
)	NULL
.	NULL

CD19	NULL
specifically	NULL
associates	NULL
with	NULL
at	NULL
least	NULL
four	NULL
other	NULL
cell	NULL
surface	NULL
proteins	NULL
to	NULL
form	NULL
a	NULL
multimolecular	NULL
complex	NULL
which	NULL
includes	NULL
the	NULL
B-cell-specific	NULL
complement	NULL
receptor	NULL
type	NULL
2	NULL
(	NULL
CD21	NULL
)	NULL
in	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

t	NULL
Present	NULL
address	NULL
:	NULL
University	NULL
of	NULL
Sussex	NULL
,	NULL
Falmer	NULL
,	NULL
Brighton	NULL
BN1	NULL
IRN	NULL
,	NULL
England	NULL
.	NULL

2662	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
CD19-CD21	NULL
complex	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
potentiate	NULL
the	NULL
primary	NULL
response	NULL
of	NULL
B	NULL
cells	NULL
to	NULL
antigen	NULL
in	NULL
vivo	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
B-cell-specific	NULL
gene	NULL
expression	NULL
is	NULL
brought	NULL
about	NULL
by	NULL
several	NULL
distinct	NULL
transcription	NULL
factors	NULL
(	NULL
reference	NULL
3	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

One	NULL
of	NULL
them	NULL
is	NULL
the	NULL
B-cell	NULL
lincage-specific	NULL
activator	NULL
protein	NULL
(	NULL
BSAP	NULL
)	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
this	NULL
transcription	NULL
factor	NULL
as	NULL
a	NULL
mammalian	NULL
homolog	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
protein	NULL
TSAP	NULL
,	NULL
which	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
developmental	NULL
and	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
two	NULL
nonallelic	NULL
pairs	NULL
of	NULL
late	NULL
histone	NULL
H2A-2	NULL
and	NULL
H2B-2	NULL
genes	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
four	NULL
TSAP-binding	NULL
sites	NULL
present	NULL
in	NULL
these	NULL
histone	NULL
gene	NULL
promoters	NULL
are	NULL
recognized	NULL
by	NULL
TSAP	NULL
with	NULL
equal	NULL
affinity	NULL
,	NULL
and	NULL
yet	NULL
they	NULL
differ	NULL
considerably	NULL
in	NULL
primary	NULL
sequence	NULL
,	NULL
allowing	NULL
the	NULL
definition	NULL
of	NULL
only	NULL
a	NULL
degenerate	NULL
consensus	NULL
sequence	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
mammalian	NULL
factor	NULL
BSAP	NULL
interacts	NULL
with	NULL
all	NULL
four	NULL
TSAP-binding	NULL
sites	NULL
in	NULL
a	NULL
manner	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
protein	NULL
.	NULL

Within	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
BSAP	NULL
is	NULL
exclusively	NULL
expressed	NULL
in	NULL
the	NULL
B-cell	NULL
lineage	NULL
with	NULL
equal	NULL
binding	NULL
activity	NULL
in	NULL
pro-B	NULL
,	NULL
pre-B	NULL
,	NULL
and	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
while	NULL
it	NULL
is	NULL
undetectable	NULL
in	NULL
terminally	NULL
differentiated	NULL
plasma	NULL
cells	NULL
.	NULL

BSAP	NULL
was	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
a	NULL
positive	NULL
transcription	NULL
factor	NULL
on	NULL
an	NULL
artificial	NULL
promoter	NULL
containing	NULL
a	NULL
sea	NULL
urchin	NULL
TSAP-binding	NULL
site	NULL
.	NULL

Known	NULL
regulatory	NULL
regions	NULL
of	NULL
immunoglobulin	NULL
and	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
genes	NULL
,	NULL
however	NULL
,	NULL
lack	NULL
high-affinity	NULL
BSAP-binding	NULL
sites	NULL
,	NULL
suggesting	NULL
that	NULL
BSAP	NULL
regulates	NULL
a	NULL
different	NULL
set	NULL
of	NULL
B-lymphoid-specific	NULL
genes	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
the	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
and	NULL
show	NULL
by	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
protein-DNA	NULL
binding	NULL
studies	NULL
that	NULL
the	NULL
CD19	NULL
promoter	NULL
is	NULL
a	NULL
target	NULL
for	NULL
the	NULL
B-cell-specific	NULL
transcription	NULL
factor	NULL
BSAP	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

The	NULL
cell	NULL
lines	NULL
Raji	NULL
,	NULL
Ramos	NULL
,	NULL
MC/CAR	NULL
,	NULL
IM-9	NULL
,	NULL
HS-Sultan	NULL
,	NULL
and	NULL
RPMI	NULL
8226	NULL
were	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

and	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
origin	NULL
of	NULL
the	NULL
other	NULL
cell	NULL
lines	NULL
used	NULL
is	NULL
described	NULL
by	NULL
Barberis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
3	NULL
)	NULL
.	NULL

Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
Screening	NULL
of	NULL
cosmid	NULL
library	NULL
,	NULL
subcloning	NULL
,	NULL
and	NULL
DNA	NULL
sequencing	NULL
.	NULL

A	NULL
human	NULL
cosmid	NULL
library	NULL
constructed	NULL
in	NULL
the	NULL
vector	NULL
pcos2-EMBL	NULL
(	NULL
8	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
A.-M.	NULL
Frischauf	NULL
(	NULL
Lon-don	NULL
,	NULL
England	NULL
)	NULL
and	NULL
screened	NULL
with	NULL
randomly	NULL
primed	NULL
insert	NULL
DNA	NULL
of	NULL
a	NULL
CD19	NULL
cDNA	NULL
clone	NULL
(	NULL
33	NULL
)	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
restriction	NULL
fragments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
were	NULL
subcloned	NULL
into	NULL
plasmid	NULL
pUC18	NULL
.	NULL

The	NULL
DNA	NULL
sequences	NULL
of	NULL
both	NULL
DNA	NULL
strands	NULL
were	NULL
determined	NULL
on	NULL
an	NULL
automated	NULL
sequencer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
model	NULL
373A	NULL
)	NULL
or	NULL
by	NULL
the	NULL
standard	NULL
dideoxy	NULL
technique	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
mouse	NULL
CD19	NULL
promoter	NULL
.	NULL

The	NULL
mouse	NULL
CD19	NULL
promoter	NULL
was	NULL
cloned	NULL
by	NULL
ligation-mediated	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
by	NULL
Fors	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
)	NULL
.	NULL

CD19-specific	NULL
oligonucleotide	NULL
primers	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
published	NULL
mouse	NULL
CD19	NULL
cDNA	NULL
sequence	NULL
(	NULL
38	NULL
)	NULL
.	NULL

PstI-digested	NULL
DNA	NULL
of	NULL
NIH	NULL
3T3	NULL
cells	NULL
and	NULL
the	NULL
oligonucleotide	NULL
CATGGCA	NULL
GCACAACATTGC	NULL
were	NULL
used	NULL
for	NULL
the	NULL
Sequenase	NULL
reaction	NULL
,	NULL
and	NULL
the	NULL
double-stranded	NULL
linker	NULL
described	NULL
by	NULL
Mueller	NULL
and	NULL
Wold	NULL
(	NULL
22	NULL
)	NULL
was	NULL
used	NULL
for	NULL
the	NULL
T4	NULL
DNA	NULL
ligase	NULL
reaction	NULL
.	NULL

The	NULL
oligonucleotide	NULL
TACCTCCACCAGTAAGGACTTCTGG	NULL
was	NULL
used	NULL
for	NULL
the	NULL
first	NULL
amplification	NULL
and	NULL
the	NULL
overlapping	NULL
oligonucleotide	NULL
ACGAGGATCCACCAGTAAGGACTTCTGGGG	NULL
CCTG	NULL
was	NULL
used	NULL
for	NULL
the	NULL
second	NULL
amplification	NULL
by	NULL
PCR	NULL
,	NULL
followed	NULL
by	NULL
EcoRI	NULL
and	NULL
BamHI	NULL
digestion	NULL
.	NULL

The	NULL
670-bp	NULL
PCR	NULL
fragment	NULL
was	NULL
cloned	NULL
into	NULL
plasmid	NULL
pSP65	NULL
and	NULL
analyzed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

In	NULL
vitro	NULL
protein-DNA	NULL
binding	NULL
assays	NULL
.	NULL

Standard	NULL
and	NULL
multiple	NULL
bandshift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Barberis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
and	NULL
by	NULL
Kozmik	NULL
and	NULL
Paces	NULL
(	NULL
16	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
la	NULL
)	NULL
.	NULL

For	NULL
methylation	NULL
protection	NULL
analysis	NULL
,	NULL
a	NULL
3'-end-labeled	NULL
DNA	NULL
fragment	NULL
(	NULL
~1	NULL
fmol	NULL
;	NULL
3,000	NULL
cpm	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
~40	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
bandshift	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
N-2-hydroxyethylpipera-zine-N'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
4	NULL
%	NULL
Ficoll	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
.	NULL

After	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
1	NULL
wl	NULL
of	NULL
dimethyl	NULL
sulfate	NULL
(	NULL
DMS	NULL
;	NULL
diluted	NULL
1:50	NULL
in	NULL
distilled	NULL
H	NULL
,	NULL
O	NULL
)	NULL
was	NULL
added	NULL
for	NULL
1	NULL
min	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
inacti-vated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
4	NULL
wl	NULL
of	NULL
1	NULL
M	NULL
B-mercaptoethanol-1.5	NULL
M	NULL
sodium	NULL
acetate	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
subjected	NULL
to	NULL
by	NULL
phenol	NULL
extraction	NULL
,	NULL
ethanol	NULL
precipitation	NULL
,	NULL
piperidine	NULL
cleav-age	NULL
,	NULL
and	NULL
analysis	NULL
on	NULL
an	NULL
8	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
.	NULL

The	NULL
in	NULL
vivo	NULL
footprinting	NULL
reaction	NULL
was	NULL
carried	NULL
out	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
of	NULL
Mueller	NULL
and	NULL
Wold	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
GGTAAGTTACTCAGCCAAGG	NULL
ACACC	NULL
was	NULL
used	NULL
as	NULL
genomic	NULL
primer	NULL
for	NULL
the	NULL
Sequenase	NULL
reaction	NULL
,	NULL
the	NULL
internal	NULL
oligonucleotide	NULL
TACCTTCCACCTITTC	NULL
ACCACTAGAGG	NULL
was	NULL
used	NULL
for	NULL
exponential	NULL
amplification	NULL
by	NULL
PCR	NULL
,	NULL
and	NULL
the	NULL
5'-end-labeled	NULL
oligonucleotide	NULL
TTCCACCTT	NULL
CACCACTAGAGGTTCCTC	NULL
was	NULL
used	NULL
for	NULL
detection	NULL
of	NULL
the	NULL
sequence	NULL
ladder	NULL
by	NULL
linear	NULL
PCR	NULL
amplification	NULL
.	NULL

The	NULL
double-stranded	NULL
linker	NULL
described	NULL
by	NULL
Mueller	NULL
and	NULL
Wold	NULL
(	NULL
22	NULL
)	NULL
was	NULL
used	NULL
for	NULL
the	NULL
T4	NULL
DNA	NULL
ligase	NULL
reaction	NULL
.	NULL

S1	NULL
nuclease	NULL
and	NULL
RNase	NULL
protection	NULL
analyses	NULL
.	NULL

S1	NULL
nuclease	NULL
and	NULL
RNase	NULL
protection	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Busslinger	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
and	NULL
Vitelli	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
human	NULL
CD19	NULL
probe	NULL
used	NULL
for	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
was	NULL
generated	NULL
by	NULL
subcloning	NULL
a	NULL
513-bp	NULL
SmaI-Mscl	NULL
fragment	NULL
of	NULL
the	NULL
CD19	NULL
cDNA	NULL
clone	NULL
(	NULL
33	NULL
)	NULL
into	NULL
the	NULL
HindII	NULL
site	NULL
of	NULL
pSP64	NULL
in	NULL
antisense	NULL
orientation	NULL
relative	NULL
to	NULL
SP6	NULL
transcription	NULL
.	NULL

For	NULL
S1	NULL
mapping	NULL
,	NULL
a	NULL
539-bp	NULL
Ncol-Pvull	NULL
fragment	NULL
of	NULL
this	NULL
subclone	NULL
was	NULL
labeled	NULL
at	NULL
the	NULL
NcoI	NULL
site	NULL
.	NULL

The	NULL
mouse	NULL
CD19	NULL
S1	NULL
probe	NULL
was	NULL
obtained	NULL
by	NULL
annealing	NULL
and	NULL
cloning	NULL
of	NULL
the	NULL
two	NULL
oligonucleotides	NULL
AATTCTATGA-93	NULL
nucleotides-CTCCTTC	NULL
TCCtgca	NULL
and	NULL
GGAGAAGGAG-93	NULL
nucleotides-TCATAG	NULL
derived	NULL
from	NULL
the	NULL
mouse	NULL
CD19	NULL
cDNA	NULL
sequence	NULL
(	NULL
34	NULL
;	NULL
5	NULL
and	NULL
3	NULL
'	NULL
REGULATION	NULL
OF	NULL
THE	NULL
CD19	NULL
GENE	NULL
BY	NULL
BSAP	NULL
2663	NULL
nucleotides	NULL
indicated	NULL
only	NULL
)	NULL
into	NULL
the	NULL
EcoRI	NULL
and	NULL
Pstl	NULL
sites	NULL
of	NULL
pSP64	NULL
.	NULL

A	NULL
262-bp	NULL
Ncol-Pvull	NULL
fragment	NULL
of	NULL
this	NULL
subclone	NULL
was	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
the	NULL
Neo	NULL
!	NULL

site	NULL
and	NULL
used	NULL
as	NULL
the	NULL
S1	NULL
probe	NULL
.	NULL

RACE	NULL
analysis	NULL
.	NULL

The	NULL
rapid	NULL
analysis	NULL
of	NULL
cDNA	NULL
ends	NULL
(	NULL
RACE	NULL
)	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
detail	NULL
by	NULL
Frohman	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
CD19-specific	NULL
oligonucleotide	NULL
TTGAGAGACG	NULL
TTGAAGATGA	NULL
was	NULL
used	NULL
to	NULL
prime	NULL
the	NULL
reverse	NULL
transcription	NULL
of	NULL
~5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
BJA-B	NULL
cells	NULL
,	NULL
followed	NULL
by	NULL
RNA	NULL
hydrolysis	NULL
with	NULL
150	NULL
mM	NULL
NaOH	NULL
for	NULL
20	NULL
min	NULL
at	NULL
60°C	NULL
,	NULL
cDNA	NULL
isolation	NULL
by	NULL
chromatography	NULL
on	NULL
a	NULL
Sephadex	NULL
SP-C50	NULL
column	NULL
,	NULL
and	NULL
ethanol	NULL
precipitation	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
tailed	NULL
with	NULL
dATP	NULL
and	NULL
terminal	NULL
deoxynucleotidyltransferase	NULL
,	NULL
followed	NULL
by	NULL
second-strand	NULL
synthesis	NULL
with	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
I	NULL
and	NULL
the	NULL
primer	NULL
TTGAGGCACTGCAGCA	NULL
(	NULL
T	NULL
)	NULL
,	NULL
,	NULL
.	NULL

CD19	NULL
sequences	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
the	NULL
oligonucleotide	NULL
TTGAGGCACTGCAGCA	NULL
,	NULL
and	NULL
the	NULL
Pstl-digested	NULL
PCR	NULL
products	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
PsfI	NULL
site	NULL
of	NULL
plasmid	NULL
pSP64	NULL
.	NULL

CD19	NULL
cDNA	NULL
clones	NULL
were	NULL
identified	NULL
by	NULL
colony	NULL
hy-bridization	NULL
with	NULL
the	NULL
end-labeled	NULL
oligonucleotide	NULL
TGACTTC	NULL
CATGGGGGTGA	NULL
and	NULL
sequenced	NULL
.	NULL

Transient	NULL
transfection	NULL
assay	NULL
.	NULL

Nine	NULL
micrograms	NULL
of	NULL
the	NULL
test	NULL
plasmid	NULL
OVEC-S	NULL
or	NULL
OVEC-CD19	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
control	NULL
plasmid	NULL
OVEC-Ref	NULL
were	NULL
transfected	NULL
into	NULL
BJA-B	NULL
,	NULL
J558L	NULL
,	NULL
and	NULL
SP2/0	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
was	NULL
extracted	NULL
48	NULL
h	NULL
later	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
analyzed	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
with	NULL
a	NULL
rabbit	NULL
B-globin	NULL
SP6	NULL
probe	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
accession	NULL
number	NULL
.	NULL

The	NULL
DNA	NULL
sequence	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenEMBL	NULL
data	NULL
base	NULL
and	NULL
assigned	NULL
accession	NULL
number	NULL
M84371	NULL
.	NULL

The	NULL
human	NULL
and	NULL
mouse	NULL
CD19	NULL
DNA	NULL
sequences	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
have	NULL
been	NULL
submitted	NULL
to	NULL
the	NULL
GenEMBL	NULL
data	NULL
base	NULL
and	NULL
assigned	NULL
accession	NULL
numbers	NULL
M84371	NULL
and	NULL
M84372	NULL
.	NULL

RESULTS	NULL
Strict	NULL
correlation	NULL
between	NULL
CD19	NULL
gene	NULL
expression	NULL
and	NULL
BSAP	NULL
activity	NULL
in	NULL
B-cell	NULL
lines	NULL
.	NULL

A	NULL
literature	NULL
search	NULL
previously	NULL
indicated	NULL
that	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
may	NULL
be	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
B-cell-specific	NULL
transcription	NULL
factor	NULL
BSAP	NULL
,	NULL
suggesting	NULL
an	NULL
involvement	NULL
of	NULL
BSAP	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
gene	NULL
(	NULL
3	NULL
)	NULL
.	NULL

As	NULL
a	NULL
first	NULL
step	NULL
towards	NULL
testing	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
this	NULL
correlation	NULL
in	NULL
more	NULL
detail	NULL
.	NULL

A	NULL
large	NULL
panel	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
previously	NULL
analyzed	NULL
for	NULL
BSAP-binding	NULL
activity	NULL
(	NULL
3	NULL
)	NULL
was	NULL
thus	NULL
analyzed	NULL
for	NULL
CD19	NULL
gene	NULL
expression	NULL
by	NULL
S1	NULL
nuclease	NULL
mapping	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

S1	NULL
probes	NULL
that	NULL
map	NULL
an	NULL
internal	NULL
portion	NULL
of	NULL
CD19	NULL
mRNA	NULL
were	NULL
generated	NULL
by	NULL
subcloning	NULL
small	NULL
fragments	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
CD19	NULL
cDNAs	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

CD19	NULL
signals	NULL
were	NULL
normalized	NULL
by	NULL
reference	NULL
to	NULL
glycer-aldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
(	NULL
gapdh	NULL
)	NULL
mRNA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
CD19	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
all	NULL
pro-B-	NULL
,	NULL
pre-B-	NULL
,	NULL
and	NULL
B-cell	NULL
lines	NULL
but	NULL
not	NULL
in	NULL
plasma	NULL
cells	NULL
,	NULL
with	NULL
two	NULL
exceptions	NULL
.	NULL

The	NULL
human	NULL
plasma	NULL
cell	NULL
line	NULL
HS-Sultan	NULL
expresses	NULL
CD19	NULL
mRNA	NULL
,	NULL
while	NULL
this	NULL
transcript	NULL
is	NULL
absent	NULL
from	NULL
the	NULL
murine	NULL
cell	NULL
line	NULL
LyD9	NULL
,	NULL
which	NULL
was	NULL
originally	NULL
described	NULL
as	NULL
a	NULL
pro-B-cell	NULL
line	NULL
(	NULL
25	NULL
)	NULL
and	NULL
was	NULL
subsequently	NULL
identified	NULL
as	NULL
a	NULL
multipotential	NULL
bone	NULL
marrow	NULL
stem	NULL
cell	NULL
clone	NULL
(	NULL
18	NULL
)	NULL
.	NULL

There	NULL
is	NULL
,	NULL
however	NULL
,	NULL
complete	NULL
correlation	NULL
between	NULL
BSAP	NULL
and	NULL
CD19	NULL
gene	NULL
expression	NULL
in	NULL
both	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
systems	NULL
,	NULL
as	NULL
all	NULL
CD19-positive	NULL
cell	NULL
lines	NULL
contain	NULL
BSAP-binding	NULL
activity	NULL
,	NULL
whereas	NULL
all	NULL
CD19-negative	NULL
cell	NULL
lines	NULL
lack	NULL
this	NULL
activity	NULL
(	NULL
3	NULL
)	NULL
.	NULL

For	NULL
all	NULL
mouse	NULL
B-lymphoid	NULL
cells	NULL
,	NULL
this	NULL
correlation	NULL
extends	NULL
even	NULL
to	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
expression	NULL
,	NULL
since	NULL
the	NULL
CD19-expressing	NULL
cell	NULL
lines	NULL
contain	NULL
not	NULL
only	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
CD19	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
but	NULL
also	NULL
similar	NULL
levels	NULL
of	NULL
BSAP-binding	NULL
activity	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
2664	NULL
KOZMIK	NULL
ET	NULL
AL	NULL
.	NULL

pro-B_	NULL
pre-B	NULL
B-cells	NULL
plasma	NULL
cells	NULL
«	NULL
©	NULL
=	NULL
G	NULL
A	NULL
33cm	NULL
--	NULL
i	NULL
-	NULL
a.	NULL
mic	NULL
“	NULL
/o	NULL
o_o	NULL
C	NULL
+-wos	NULL
§	NULL
-	NULL
o	NULL
n	NULL
--	NULL
``	NULL
®~o	NULL
-	NULL
=	NULL
i	NULL
F	NULL
=	NULL
,	NULL
&	NULL
%	NULL
&	NULL
n	NULL
a	NULL
a	NULL
9	NULL
§	NULL
8	NULL
P	NULL
o	NULL
8	NULL
s	NULL
T	NULL
T	NULL
s	NULL
O	NULL
o	NULL
c	NULL
©	NULL
n	NULL
&	NULL
4	NULL
T	NULL
T	NULL
I	NULL
-L	NULL
R	NULL
s	NULL
s	NULL
m	NULL
a	NULL
3	NULL
3	NULL
a	NULL
o	NULL
{	NULL
7	NULL
--	NULL
tae	NULL
«	NULL
ap	NULL
10	NULL
B9	NULL
-	NULL
-	NULL
Sp	NULL
M9900	NULL
moos	NULL
duos	NULL
vs	NULL
tees	NULL
cog	NULL
=s	NULL
:	NULL
<	NULL
i	NULL
>	NULL
=	NULL
67	NULL
-	NULL
|	NULL
wee	NULL
-o	NULL
b	NULL
dob	NULL
#	NULL
#	NULL
#	NULL
#	NULL
#	NULL
>	NULL
o	NULL
>	NULL
-	NULL
<	NULL
-	NULL
BSAP	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bro	NULL
.	NULL

pro-B	NULL
pre-B	NULL
.	NULL

B-cells	NULL
H	NULL
cu	NULL
28	NULL
U	NULL
<	NULL
0	NULL
o.	NULL
I	NULL
CC	NULL
[	NULL
o	NULL
L	NULL
NAMALWA	NULL
RAJI	NULL
MC/CAR	NULL
FLEB14	NULL
NALM6	NULL
REH	NULL
BJA-B	NULL
RAMOS	NULL
IM-9	NULL
500	NULL
I	NULL
b	NULL
I	NULL
404	NULL
353	NULL
242	NULL
A	NULL
,	NULL
-	NULL
:	NULL
s	NULL
:	NULL
:	NULL
nous	NULL
weg	NULL
moim	NULL
bows	NULL
mus	NULL
Willie	NULL
mame	NULL
came	NULL
mum	NULL
coe	NULL
500	NULL
404	NULL
wae	NULL
aus	NULL
oun	NULL
oun	NULL
ane	NULL
all	NULL
>	NULL
can	NULL
can	NULL
cu	NULL
»	NULL
can	NULL
cue	NULL
cns	NULL
353	NULL
.	NULL

--	NULL
dip	NULL
--	NULL
amendiban	NULL
-	NULL
as	NULL
«	NULL
s	NULL
-	NULL
CD1	NULL
242	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

CD19	NULL
gene	NULL
expression	NULL
in	NULL
murine	NULL
and	NULL
human	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Murine	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
of	NULL
each	NULL
cell	NULL
line	NULL
was	NULL
simultaneously	NULL
analyzed	NULL
by	NULL
S1	NULL
nuclease	NULL
mapping	NULL
with	NULL
a	NULL
5'-end-labeled	NULL
mouse	NULL
CD19	NULL
and	NULL
a	NULL
rat	NULL
gapdh	NULL
S1	NULL
probe	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
radioactivity	NULL
of	NULL
the	NULL
gapdh	NULL
probe	NULL
was	NULL
10-fold	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
CD19	NULL
probe	NULL
.	NULL

Sl-resistant	NULL
DNA	NULL
fragments	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide	NULL
sequencing	NULL
gel	NULL
together	NULL
with	NULL
an	NULL
end-labeled	NULL
DNA	NULL
size	NULL
marker	NULL
(	NULL
lane	NULL
M	NULL
;	NULL
pUC18	NULL
digested	NULL
with	NULL
MspI	NULL
)	NULL
.	NULL

Input	NULL
denotes	NULL
the	NULL
position	NULL
of	NULL
the	NULL
two	NULL
intact	NULL
S1	NULL
DNA	NULL
probes	NULL
.	NULL

Correct	NULL
protection	NULL
by	NULL
the	NULL
CD19	NULL
mRNA	NULL
results	NULL
in	NULL
an	NULL
88-nucleotide-long	NULL
Sl-resistant	NULL
DNA	NULL
fragment	NULL
.	NULL

The	NULL
triplet	NULL
below	NULL
it	NULL
is	NULL
generated	NULL
by	NULL
S1	NULL
digestion	NULL
into	NULL
an	NULL
A+T-rich	NULL
sequence	NULL
of	NULL
the	NULL
RNA-DNA	NULL
hybrid	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
previously	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
BSAP-binding	NULL
activity	NULL
,	NULL
as	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
(	NULL
3	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Human	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
of	NULL
each	NULL
cell	NULL
line	NULL
was	NULL
separately	NULL
analyzed	NULL
with	NULL
a	NULL
human	NULL
gapdh	NULL
and	NULL
a	NULL
human	NULL
CD19	NULL
S1	NULL
probe	NULL
.	NULL

Bandshift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
with	NULL
a	NULL
sea	NULL
urchin	NULL
TSAP	NULL
probe	NULL
revealed	NULL
the	NULL
same	NULL
amount	NULL
(	NULL
+	NULL
)	NULL
of	NULL
BSAP	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
Ramos	NULL
,	NULL
MC/CAR	NULL
,	NULL
IM-9	NULL
,	NULL
and	NULL
HS-Sultan	NULL
as	NULL
in	NULL
the	NULL
other	NULL
previously	NULL
analyzed	NULL
cell	NULL
lines	NULL
(	NULL
3	NULL
)	NULL
,	NULL
while	NULL
RPMI	NULL
8226	NULL
cells	NULL
lack	NULL
BSAP	NULL
activity	NULL
(	NULL
-	NULL
)	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
autoradiographic	NULL
exposure	NULL
time	NULL
for	NULL
both	NULL
CD19	NULL
S1	NULL
gels	NULL
was	NULL
7	NULL
days	NULL
at	NULL
-70°C	NULL
.	NULL

Sizes	NULL
are	NULL
indicated	NULL
in	NULL
nucleotides	NULL
.	NULL

strict	NULL
correlation	NULL
between	NULL
CD19	NULL
and	NULL
BSAP	NULL
expression	NULL
supports	NULL
our	NULL
hypothesis	NULL
that	NULL
the	NULL
CD19	NULL
gene	NULL
is	NULL
a	NULL
target	NULL
for	NULL
BSAP	NULL
regulation	NULL
and	NULL
predicts	NULL
that	NULL
a	NULL
BSAP-binding	NULL
site	NULL
(	NULL
s	NULL
)	NULL
should	NULL
be	NULL
part	NULL
of	NULL
the	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
.	NULL

An	NULL
alternative	NULL
explanation	NULL
is	NULL
that	NULL
another	NULL
transcription	NULL
factor	NULL
with	NULL
the	NULL
same	NULL
expression	NULL
profile	NULL
regulates	NULL
both	NULL
the	NULL
CD19	NULL
and	NULL
BSAP	NULL
genes	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
two	NULL
possibilities	NULL
,	NULL
we	NULL
cloned	NULL
and	NULL
analyzed	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
.	NULL

The	NULL
Bam	NULL
HI	NULL
L7	NULL
:	NULL
Hind	NULL
IZ	NULL
CD19	NULL
gene	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
genomic	NULL
cosmid	NULL
library	NULL
by	NULL
screening	NULL
with	NULL
a	NULL
homologous	NULL
cDNA	NULL
probe	NULL
(	NULL
33	NULL
)	NULL
.	NULL

One	NULL
of	NULL
several	NULL
positive	NULL
cosmid	NULL
clones	NULL
was	NULL
further	NULL
characterized	NULL
by	NULL
subcloning	NULL
and	NULL
DNA	NULL
sequencing	NULL
.	NULL

Comparison	NULL
with	NULL
published	NULL
cDNA	NULL
sequences	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
revealed	NULL
that	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
is	NULL
7.37	NULL
kb	NULL
long	NULL
and	NULL
consists	NULL
of	NULL
15	NULL
exons	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
first	NULL
four	NULL
exons	NULL
encode	NULL
the	NULL
N-terminal	NULL
extracellular	NULL
domain	NULL
,	NULL
exon	NULL
5	NULL
contains	NULL
the	NULL
transmembrane	NULL
region	NULL
,	NULL
and	NULL
exons	NULL
6	NULL
to	NULL
14	NULL
code	NULL
for	NULL
the	NULL
intracellular	NULL
portion	NULL
of	NULL
the	NULL
[	NULL
~-	NULL
Xba	NULL
I	NULL
£Sac	NULL
-s	NULL
by	NULL
to	NULL
&	NULL
I	NULL
HA	NULL
1	NULL
1	NULL
kb	NULL
Km_-_	NULL
--	NULL
--	NULL
--	NULL
A	NULL
&	NULL
M	NULL
I2	NULL
CAL	NULL
_	NULL
in	NULL
7	NULL
8	NULL
9	NULL
101112	NULL
13	NULL
14	NULL
15	NULL
kp	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
XS	NULL
-__-	NULL
I	NULL
--	NULL
--	NULL
--	NULL
AK	NULL
--	NULL
-	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Exon-intron	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
.	NULL

Coding	NULL
and	NULL
noncoding	NULL
exons	NULL
are	NULL
indicated	NULL
by	NULL
black	NULL
and	NULL
open	NULL
boxes	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
thick	NULL
line	NULL
denotes	NULL
the	NULL
regions	NULL
which	NULL
have	NULL
been	NULL
sequenced	NULL
.	NULL

Vector	NULL
sequences	NULL
are	NULL
indicated	NULL
by	NULL
a	NULL
wavy	NULL
line	NULL
.	NULL

Only	NULL
the	NULL
restriction	NULL
enzyme	NULL
sites	NULL
used	NULL
for	NULL
generating	NULL
the	NULL
three	NULL
subclones	NULL
are	NULL
shown	NULL
.	NULL

TM	NULL
,	NULL
transmembrane	NULL
domain	NULL
.	NULL

Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
REGULATION	NULL
OF	NULL
THE	NULL
CD19	NULL
GENE	NULL
BY	NULL
BSAP	NULL
2665	NULL
A	NULL
B	NULL
Fo	NULL
Fel	NULL
&	NULL
§	NULL
fx	NULL
3	NULL
a	NULL
2	NULL
A	NULL
m	NULL
2	NULL
CA	NULL
I	NULL
4	NULL
2	NULL
J	NULL
<	NULL
a	NULL
o	NULL
6	NULL
s	NULL
E	NULL
a	NULL
&	NULL
£	NULL
m	NULL
a	NULL
&	NULL
woe	NULL
,	NULL
_	NULL
a	NULL
110-	NULL
4	NULL
“	NULL
8	NULL
-	NULL
=	NULL
M	NULL
_	NULL
94-	NULL
4	NULL
wt	NULL
#	NULL
ares	NULL
OB	NULL
-	NULL
\	NULL
7	NULL
,	NULL
C	NULL
``	NULL
as	NULL
|	NULL
1	NULL
67-	NULL
lis	NULL
worse	NULL
gous	NULL
#	NULL
08	NULL
song	NULL
gll	NULL
4	NULL
.	NULL

(	NULL
aPC	NULL
)	NULL
C	NULL
+	NULL
published	NULL
cDNA	NULL
B	NULL
EH	NULL
B	NULL
t	NULL
-f	NULL
r	NULL
>	NULL
+	NULL
+	NULL
Urei	NULL
I	NULL
I	NULL
11	NULL
I	NULL
[	NULL
RACE	NULL
CCTCCAGGCCCCTGCCTGCCCCAGCATCCCCTGCGCGAAGCTGGGTGCCCCGGAGAGTCTGACCACCATG	NULL
¥Y	NULL
T	NULL
TTY	NULL
¥	NULL
71	NULL
¥	NULL
7	NULL
CCTCCAGGCCCCTGCCTGCCCCAGCATCCCCTGCGCGAAGC	NULL
TGGGTGCCCCGGAGAGTCYGACCACCATE	NULL
?	NULL

S1	NULL
GGAGGTCCGGGGACCGACGGGGTCGTAGGGGACGCGCTTCGACCCACGGGGCCTCTCAGAC	NULL
TGG	NULL
TGG	NULL
TA	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
initiation	NULL
sites	NULL
of	NULL
CD19	NULL
gene	NULL
transcription	NULL
.	NULL

(	NULL
A	NULL
)	NULL
S1	NULL
nuclease	NULL
analysis	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
~5	NULL
pug	NULL
)	NULL
of	NULL
each	NULL
cell	NULL
line	NULL
was	NULL
analyzed	NULL
by	NULL
S1	NULL
mapping	NULL
with	NULL
a	NULL
DNA	NULL
probe	NULL
that	NULL
was	NULL
end	NULL
labeled	NULL
at	NULL
an	NULL
Aval	NULL
site	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
and	NULL
that	NULL
extends	NULL
300	NULL
bp	NULL
up	NULL
to	NULL
the	NULL
next	NULL
Xbal	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

Sl-resistant	NULL
DNA	NULL
fragments	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
denaturing	NULL
8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
together	NULL
with	NULL
the	NULL
cleavage	NULL
products	NULL
of	NULL
the	NULL
G+A	NULL
sequencing	NULL
reaction	NULL
of	NULL
the	NULL
same	NULL
DNA	NULL
probe	NULL
.	NULL

One-tenth	NULL
of	NULL
each	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
~0.5	NULL
ug	NULL
)	NULL
was	NULL
standardized	NULL
in	NULL
a	NULL
separate	NULL
S1	NULL
experiment	NULL
with	NULL
a	NULL
human	NULL
gapdh	NULL
DNA	NULL
probe	NULL
.	NULL

The	NULL
nucleotide	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
labeled	NULL
Aval	NULL
end	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RNase	NULL
protection	NULL
experiment	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
20	NULL
g	NULL
)	NULL
of	NULL
BJA-B	NULL
and	NULL
RPMI	NULL
8226	NULL
cells	NULL
was	NULL
hybridized	NULL
to	NULL
a	NULL
riboprobe	NULL
containing	NULL
the	NULL
CD19	NULL
sequences	NULL
from	NULL
the	NULL
Aval	NULL
site	NULL
(	NULL
exon	NULL
1	NULL
)	NULL
to	NULL
the	NULL
Xbel	NULL
site	NULL
(	NULL
promoter	NULL
)	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
RNase	NULL
digestion	NULL
and	NULL
analysis	NULL
on	NULL
an	NULL
8	NULL
%	NULL
sequencing	NULL
gel	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
36	NULL
)	NULL
.	NULL

An	NULL
end-labeled	NULL
MspI	NULL
digest	NULL
of	NULL
pUC19	NULL
DNA	NULL
was	NULL
used	NULL
as	NULL
size	NULL
marker	NULL
(	NULL
lane	NULL
M	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Summary	NULL
of	NULL
5'-end	NULL
mapping	NULL
.	NULL

The	NULL
RACE	NULL
method	NULL
was	NULL
used	NULL
to	NULL
clone	NULL
the	NULL
5'-terminal	NULL
sequences	NULL
of	NULL
CD19	NULL
mRNA	NULL
from	NULL
BJA-B	NULL
cells	NULL
.	NULL

Twenty-one	NULL
cDNA	NULL
clones	NULL
were	NULL
sequenced	NULL
,	NULL
and	NULL
their	NULL
starting	NULL
nucleotides	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
published	NULL
cDNA	NULL
sequence	NULL
(	NULL
33	NULL
)	NULL
starts	NULL
15	NULL
nucleotides	NULL
upstream	NULL
of	NULL
the	NULL
translation	NULL
start	NULL
codon	NULL
,	NULL
which	NULL
is	NULL
underlined	NULL
.	NULL

The	NULL
transcription	NULL
initiation	NULL
sites	NULL
as	NULL
mapped	NULL
by	NULL
S1	NULL
nuclease	NULL
analysis	NULL
are	NULL
indicated	NULL
below	NULL
by	NULL
filled	NULL
and	NULL
open	NULL
arrowheads	NULL
corresponding	NULL
to	NULL
intense	NULL
and	NULL
weak	NULL
S1	NULL
signals	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
number	NULL
of	NULL
transcription	NULL
start	NULL
sites	NULL
may	NULL
have	NULL
been	NULL
overestimated	NULL
by	NULL
S1	NULL
nuclease	NULL
mapping	NULL
in	NULL
comparison	NULL
with	NULL
the	NULL
RNase	NULL
protection	NULL
experiment	NULL
,	NULL
possibly	NULL
because	NULL
of	NULL
``	NULL
nibbling	NULL
``	NULL
of	NULL
the	NULL
S1	NULL
nuclease	NULL
at	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
protected	NULL
DNA	NULL
fragments	NULL
.	NULL

CD19	NULL
protein	NULL
.	NULL

The	NULL
CD19	NULL
cosmid	NULL
clone	NULL
analyzed	NULL
contains	NULL
1.3	NULL
kb	NULL
and	NULL
~30	NULL
kb	NULL
of	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
flanking	NULL
sequences	NULL
,	NULL
respectively	NULL
.	NULL

Heterogeneous	NULL
initiation	NULL
of	NULL
CD19	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
relatively	NULL
rare	NULL
CD19	NULL
mRNA	NULL
were	NULL
mapped	NULL
by	NULL
three	NULL
different	NULL
,	NULL
highly	NULL
sensitive	NULL
methods	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
used	NULL
for	NULL
S1	NULL
nuclease	NULL
analysis	NULL
with	NULL
a	NULL
DNA	NULL
probe	NULL
that	NULL
was	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
the	NULL
Aveal	NULL
site	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

An	NULL
identical	NULL
pattern	NULL
of	NULL
heterogeneous	NULL
start	NULL
sites	NULL
was	NULL
observed	NULL
for	NULL
three	NULL
CD19-positive	NULL
cell	NULL
lines	NULL
(	NULL
MC/CAR	NULL
,	NULL
REH	NULL
,	NULL
BJA-B	NULL
)	NULL
.	NULL

Alignment	NULL
with	NULL
the	NULL
control	NULL
sequence	NULL
ladder	NULL
(	NULL
G+A	NULL
)	NULL
mapped	NULL
these	NULL
start	NULL
sites	NULL
within	NULL
a	NULL
40-bp-long	NULL
,	NULL
highly	NULL
G+C-rich	NULL
DNA	NULL
sequence	NULL
immediately	NULL
adjacent	NULL
to	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
pattern	NULL
of	NULL
heterogeneous	NULL
start	NULL
sites	NULL
was	NULL
obtained	NULL
by	NULL
RNase	NULL
protection	NULL
analysis	NULL
of	NULL
BJA-B	NULL
RNA	NULL
with	NULL
an	NULL
antisense	NULL
RNA	NULL
probe	NULL
that	NULL
spans	NULL
the	NULL
same	NULL
sequences	NULL
used	NULL
for	NULL
S1	NULL
mapping	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
the	NULL
5°	NULL
ends	NULL
of	NULL
CD19	NULL
transcripts	NULL
in	NULL
BJA-B	NULL
RNA	NULL
by	NULL
the	NULL
RACE	NULL
procedure	NULL
(	NULL
10	NULL
;	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Twenty-one	NULL
independent	NULL
cDNA	NULL
clones	NULL
were	NULL
isolated	NULL
,	NULL
and	NULL
their	NULL
starting	NULL
nucleotides	NULL
were	NULL
determined	NULL
by	NULL
DNA	NULL
sequencing	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
shortest	NULL
of	NULL
these	NULL
cDNA	NULL
clones	NULL
corresponded	NULL
to	NULL
the	NULL
5°	NULL
end	NULL
of	NULL
the	NULL
published	NULL
CD19	NULL
cDNA	NULL
sequence	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
all	NULL
three	NULL
methods	NULL
revealed	NULL
heterogeneous	NULL
initiation	NULL
of	NULL
CD19	NULL
gene	NULL
transcription	NULL
within	NULL
a	NULL
40-bp	NULL
G+C-rich	NULL
DNA	NULL
sequence	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
finding	NULL
,	NULL
there	NULL
is	NULL
no	NULL
TATA-like	NULL
sequence	NULL
in	NULL
the	NULL
immediate	NULL
upstream	NULL
region	NULL
.	NULL

Mapping	NULL
of	NULL
BSAP-binding	NULL
sites	NULL
in	NULL
the	NULL
CD19	NULL
gene	NULL
.	NULL

An	NULL
important	NULL
prerequisite	NULL
for	NULL
the	NULL
rapid	NULL
identification	NULL
of	NULL
BSAP-binding	NULL
sites	NULL
on	NULL
the	NULL
CD19	NULL
cosmid	NULL
clone	NULL
was	NULL
the	NULL
availability	NULL
of	NULL
partially	NULL
pure	NULL
BSAP	NULL
protein	NULL
,	NULL
which	NULL
was	NULL
isolated	NULL
from	NULL
BJA-B	NULL
cells	NULL
by	NULL
a	NULL
two-step	NULL
procedure	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Typically	NULL
,	NULL
BSAP	NULL
represented	NULL
~10	NULL
%	NULL
of	NULL
the	NULL
total	NULL
protein	NULL
in	NULL
the	NULL
final	NULL
fraction	NULL
,	NULL
corresponding	NULL
to	NULL
a	NULL
5,000-fold	NULL
enrichment	NULL
.	NULL

Such	NULL
a	NULL
BSAP	NULL
preparation	NULL
was	NULL
used	NULL
for	NULL
multiple	NULL
bandshift	NULL
assay	NULL
(	NULL
16	NULL
)	NULL
.	NULL

An	NULL
end-labeled	NULL
MspI	NULL
digest	NULL
of	NULL
the	NULL
CD19	NULL
cosmid	NULL
DNA	NULL
was	NULL
incubated	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
BSAP	NULL
prior	NULL
to	NULL
separation	NULL
on	NULL
a	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
prediction	NULL
2666	NULL
KOZMIK	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
BSAP	NULL
(	NULL
ul	NULL
)	NULL
-	NULL
1	NULL
2	NULL
2	NULL
2	NULL
competitor	NULL
.	NULL

-	NULL
-	NULL
-	NULL
1	NULL
50	NULL
(	NULL
ng	NULL
)	NULL
|	NULL
|	NULL
w	NULL
O	NULL
Om	NULL
m	NULL
v	NULL
v	NULL
vy	NULL
v	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

BSAP	NULL
BSAP	NULL
G+A	NULL
<	NULL
+	NULL
(	NULL
5	NULL
+	NULL
3	NULL
21	NULL
4	NULL
5	NULL
6	NULL
RNRL	NULL
Ig	NULL
LL	NULL
Le	NULL
an	NULL
accra	NULL
cca	NULL
locs	NULL
m	NULL
Rit	NULL
-	NULL
AON	NULL
--	NULL
-	NULL
O	NULL
--	NULL
A	NULL
-a	NULL
a	NULL
--	NULL
-	NULL
&	NULL
M	NULL
MH	NULL
___-	NULL
C77	NULL
,	NULL
”	NULL
ﬁfA	NULL
;	NULL
due	NULL
wae	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
hee	NULL
sare	NULL
~	NULL
ame	NULL
tne	NULL
wns	NULL
sna	NULL
C	NULL
|	NULL
w	NULL
»	NULL
|	NULL
«	NULL
m	NULL
.	NULL

atte	NULL
~-	NULL
f	NULL
C	NULL
|	NULL
I	NULL
B	NULL
L	NULL
_	NULL
M	NULL
M	NULL
_	NULL
8,77	NULL
”	NULL
,	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Identification	NULL
of	NULL
BSAP-binding	NULL
sites	NULL
in	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
(	NULL
A	NULL
)	NULL
Multiple	NULL
bandshift	NULL
assay	NULL
.	NULL

An	NULL
end-labeled	NULL
MspI	NULL
digest	NULL
of	NULL
CD19	NULL
cosmid	NULL
DNA	NULL
was	NULL
incubated	NULL
with	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
or	NULL
without	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
purified	NULL
BSAP	NULL
protein	NULL
prior	NULL
to	NULL
electrophoretic	NULL
separation	NULL
on	NULL
a	NULL
native	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
TSAP-binding	NULL
site	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
H2A-2.2	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
a	NULL
specific	NULL
competitor	NULL
in	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
MspI	NULL
fragments	NULL
with	NULL
BSAP-binding	NULL
sites	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
.	NULL

MspI	NULL
fragments	NULL
A	NULL
to	NULL
C	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
Accel	NULL
site	NULL
of	NULL
plasmid	NULL
pSP64	NULL
,	NULL
and	NULL
end-labeled	NULL
DNA	NULL
fragments	NULL
containing	NULL
these	NULL
inserts	NULL
were	NULL
used	NULL
for	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
purified	NULL
BSAP	NULL
protein	NULL
.	NULL

A	NULL
map	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
is	NULL
shown	NULL
below	NULL
;	NULL
the	NULL
positions	NULL
of	NULL
MspI	NULL
fragments	NULL
A	NULL
to	NULL
C	NULL
and	NULL
the	NULL
six	NULL
DNase	NULL
I-protected	NULL
BSAP-binding	NULL
sites	NULL
are	NULL
indicated	NULL
.	NULL

H	NULL
,	NULL
high-affinity	NULL
BSAP-binding	NULL
site	NULL
;	NULL
M	NULL
,	NULL
BSAP	NULL
site	NULL
with	NULL
an	NULL
affinity	NULL
4-fold	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
TSAP-binding	NULL
sites	NULL
;	NULL
L	NULL
,	NULL
BSAP	NULL
site	NULL
with	NULL
an	NULL
affinity	NULL
16-fold	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
TSAP-binding	NULL
sites	NULL
.	NULL

was	NULL
that	NULL
any	NULL
DNA	NULL
fragment	NULL
containing	NULL
one	NULL
or	NULL
more	NULL
BSAP-binding	NULL
sites	NULL
should	NULL
form	NULL
a	NULL
complex	NULL
upon	NULL
BSAP	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
and	NULL
thus	NULL
be	NULL
retarded	NULL
in	NULL
its	NULL
migration	NULL
relative	NULL
to	NULL
the	NULL
unbound	NULL
DNA	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
MspI	NULL
fragments	NULL
labeled	NULL
A	NULL
to	NULL
H	NULL
(	NULL
except	NULL
for	NULL
C	NULL
)	NULL
clearly	NULL
showed	NULL
this	NULL
behavior	NULL
,	NULL
and	NULL
furthermore	NULL
,	NULL
their	NULL
retardation	NULL
was	NULL
prevented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
specific	NULL
competitor	NULL
DNA	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixture	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
MspI	NULL
digestion	NULL
pattern	NULL
of	NULL
the	NULL
entire	NULL
cosmid	NULL
clone	NULL
with	NULL
that	NULL
of	NULL
three	NULL
different	NULL
subclones	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
allowed	NULL
us	NULL
to	NULL
map	NULL
fragments	NULL
A	NULL
and	NULL
C	NULL
to	NULL
the	NULL
5	NULL
'	NULL
region	NULL
(	NULL
clone	NULL
HA	NULL
)	NULL
,	NULL
fragment	NULL
B	NULL
to	NULL
the	NULL
central	NULL
part	NULL
(	NULL
clone	NULL
AX	NULL
)	NULL
,	NULL
and	NULL
fragment	NULL
H	NULL
to	NULL
the	NULL
3	NULL
'	NULL
part	NULL
(	NULL
clone	NULL
XS	NULL
)	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
(	NULL
15a	NULL
)	NULL
.	NULL

Fragments	NULL
D	NULL
to	NULL
G	NULL
must	NULL
therefore	NULL
originate	NULL
from	NULL
the	NULL
3	NULL
'	NULL
flanking	NULL
sequences	NULL
.	NULL

No	NULL
BSAP-binding	NULL
sites	NULL
were	NULL
mapped	NULL
to	NULL
MspI	NULL
fragments	NULL
of	NULL
the	NULL
cosmid	NULL
vector	NULL
.	NULL

The	NULL
MspI	NULL
fragments	NULL
A	NULL
and	NULL
B	NULL
were	NULL
subcloned	NULL
,	NULL
and	NULL
their	NULL
precise	NULL
positions	NULL
on	NULL
the	NULL
CD19	NULL
map	NULL
were	NULL
determined	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

BSAP	NULL
recognition	NULL
sequences	NULL
within	NULL
these	NULL
DNA	NULL
fragments	NULL
were	NULL
then	NULL
identified	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprints	NULL
1	NULL
to	NULL
6	NULL
could	NULL
all	NULL
be	NULL
competed	NULL
for	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
a	NULL
wild-type	NULL
but	NULL
not	NULL
a	NULL
mutant	NULL
BSAP-binding	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
REGULATION	NULL
OF	NULL
THE	NULL
CD19	NULL
GENE	NULL
BY	NULL
BSAP	NULL
2667	NULL
C	NULL
B	NULL
site	NULL
1	NULL
site	NULL
2	NULL
a	NULL
5	NULL
$	NULL
5	NULL
BSAP	NULL
BSAP	NULL
F	NULL
B	NULL
FB	NULL
FB	NULL
FOB	NULL
£	NULL
.	NULL

site	NULL
1	NULL
to	NULL
2	NULL
probes	NULL
-	NULL
»	NULL
_	NULL
I~=	NULL
1	NULL
site	NULL
ji	NULL
~	NULL
mesin	NULL
g	NULL
=m	NULL
***	NULL
BSAP	NULL
--	NULL
-	NULL
CHH	NULL
@	NULL
mus	NULL
aqua	NULL
am	NULL
gans	NULL
Meee	NULL
``	NULL
``	NULL
``	NULL
___	NULL
neue	NULL
mae	NULL
ww	NULL
same	NULL
—-	NULL
>	NULL
wor	NULL
mace	NULL
w	NULL
o	NULL
uas	NULL
a	NULL
%	NULL
[	NULL
_J	NULL
4	NULL
«	NULL
-	NULL
``	NULL
``	NULL
,	NULL
uae	NULL
1	NULL
eas	NULL
__	NULL
<	NULL
T=	NULL
<	NULL
mm	NULL
L2	NULL
.	NULL

&	NULL
competitor	NULL
€	NULL
»	NULL
»	NULL
mp	NULL
«	NULL
ume	NULL
a	NULL
ws	NULL
-	NULL
<	NULL
-	NULL
<	NULL
5	NULL
soe	NULL
<	NULL
TSAP	NULL
(	NULL
H2A-2.2	NULL
)	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
-	NULL
sue	NULL
f	NULL
Pu	NULL
(	NULL
SV40	NULL
)	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
mane	NULL
wost	NULL
wee	NULL
C	NULL
La	NULL
*	NULL
A	NULL
Y-site	NULL
1	NULL
CCCCCGCAGACACCCATGGTTGAGTGCCCTCCAGGCCCCTGCCTG	NULL
Wewe	NULL
lear	NULL
GGGGGCGTCTGTGGGTACCAACTCACGGGAGGTCCGGGGACGGAC	NULL
A	NULL
A	NULL
A	NULL
v	NULL
--	NULL
-	NULL
#	NULL
#	NULL
*-TY	NULL
¥	NULL
Y	NULL
site	NULL
2	NULL
CCTGGAGAATGGGGCCTGAGGCGTGACCACCGCCTTCCTCTCTGG	NULL
GGACCTCTTACCCCGGACTCCGCACTGGTGGCGGAAGGAGAGACC	NULL
A	NULL
A	NULL
I	NULL
upper	NULL
lower	NULL
upper	NULL
lower	NULL
strand	NULL
strand	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Interaction	NULL
of	NULL
BSAP	NULL
with	NULL
the	NULL
two	NULL
promoter-proximal	NULL
binding	NULL
sites	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Bandshift	NULL
assay	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
TSAP-binding	NULL
site	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
H2A-2.2	NULL
gene	NULL
(	NULL
2	NULL
)	NULL
and	NULL
the	NULL
two	NULL
CD19	NULL
oligonucieotides	NULL
shown	NULL
below	NULL
were	NULL
used	NULL
as	NULL
end-labeled	NULL
probes	NULL
for	NULL
bandshift	NULL
assay	NULL
with	NULL
a	NULL
nuclear	NULL
extract	NULL
of	NULL
BJA-B	NULL
cells	NULL
.	NULL

A	NULL
100-fold	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
TSAP-binding	NULL
site	NULL
and	NULL
of	NULL
the	NULL
Pu	NULL
motif	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
enhancer	NULL
(	NULL
26	NULL
)	NULL
was	NULL
added	NULL
as	NULL
competitor	NULL
DNA	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
where	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Methylation	NULL
interference	NULL
analysis	NULL
.	NULL

The	NULL
two	NULL
oligonucleotides	NULL
shown	NULL
in	NULL
panel	NULL
C	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
Sa/l	NULL
site	NULL
of	NULL
pSP64	NULL
,	NULL
and	NULL
HindIII-EcoRI	NULL
restriction	NULL
fragments	NULL
that	NULL
were	NULL
5	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
either	NULL
the	NULL
HindIII	NULL
or	NULL
EcoRI	NULL
site	NULL
were	NULL
used	NULL
for	NULL
methylation	NULL
interference	NULL
analysis	NULL
with	NULL
purified	NULL
BSAP	NULL
protein	NULL
.	NULL

F	NULL
and	NULL
B	NULL
denote	NULL
free	NULL
and	NULL
bound	NULL
DNA	NULL
,	NULL
respectively	NULL
.	NULL

Black	NULL
arrowheads	NULL
point	NULL
to	NULL
methylated	NULL
G	NULL
residues	NULL
that	NULL
interfere	NULL
with	NULL
BSAP	NULL
binding	NULL
,	NULL
and	NULL
open	NULL
arrowheads	NULL
indicate	NULL
G	NULL
residues	NULL
that	NULL
enhance	NULL
protein	NULL
binding	NULL
upon	NULL
methylation	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Summary	NULL
of	NULL
BSAP	NULL
interaction	NULL
with	NULL
sites	NULL
1	NULL
and	NULL
2	NULL
.	NULL

The	NULL
CD19	NULL
promoter	NULL
sequences	NULL
used	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
are	NULL
shown	NULL
.	NULL

Brackets	NULL
above	NULL
and	NULL
below	NULL
the	NULL
DNA	NULL
sequences	NULL
indicate	NULL
the	NULL
extent	NULL
of	NULL
the	NULL
DNase	NULL
I	NULL
protection	NULL
by	NULL
BSAP	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
6	NULL
)	NULL
,	NULL
and	NULL
arrowheads	NULL
denote	NULL
methylated	NULL
G	NULL
residues	NULL
that	NULL
either	NULL
interfere	NULL
with	NULL
(	NULL
filled	NULL
)	NULL
or	NULL
enhance	NULL
(	NULL
open	NULL
)	NULL
BSAP	NULL
binding	NULL
.	NULL

G	NULL
residues	NULL
that	NULL
are	NULL
protected	NULL
by	NULL
BSAP	NULL
in	NULL
the	NULL
DMS	NULL
footprint	NULL
experiment	NULL
of	NULL
Fig	NULL
.	NULL

6	NULL
are	NULL
marked	NULL
by	NULL
asterisks	NULL
.	NULL

site	NULL
,	NULL
demonstrating	NULL
that	NULL
all	NULL
six	NULL
footprints	NULL
are	NULL
generated	NULL
by	NULL
BSAP	NULL
(	NULL
15a	NULL
)	NULL
.	NULL

Fragment	NULL
C	NULL
did	NULL
not	NULL
score	NULL
positive	NULL
in	NULL
the	NULL
multiple	NULL
bandshift	NULL
assay	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
comigration	NULL
with	NULL
another	NULL
DNA	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

It	NULL
was	NULL
cloned	NULL
only	NULL
as	NULL
a	NULL
contamination	NULL
of	NULL
fragment	NULL
B	NULL
and	NULL
subsequently	NULL
proved	NULL
to	NULL
contain	NULL
a	NULL
-binding	NULL
site	NULL
upon	NULL
DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
six	NULL
DNase	NULL
I-protected	NULL
sequences	NULL
were	NULL
used	NULL
for	NULL
the	NULL
bandshift	NULL
competition	NULL
assay	NULL
to	NULL
measure	NULL
their	NULL
relative	NULL
affinities	NULL
for	NULL
BSAP	NULL
.	NULL

These	NULL
experiments	NULL
revealed	NULL
that	NULL
only	NULL
site	NULL
1	NULL
exhibits	NULL
the	NULL
same	NULL
high	NULL
affinity	NULL
as	NULL
do	NULL
the	NULL
sea	NULL
urchin	NULL
TSAP-binding	NULL
sites	NULL
,	NULL
while	NULL
sites	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
are	NULL
of	NULL
medium	NULL
affinity	NULL
and	NULL
site	NULL
4	NULL
is	NULL
of	NULL
low	NULL
affinity	NULL
(	NULL
unpublished	NULL
data	NULL
;	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
high-affinity	NULL
BSAP-binding	NULL
site	NULL
1	NULL
is	NULL
located	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
heterogeneous	NULL
transcription	NULL
start	NULL
sites	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
in	NULL
a	NULL
position	NULL
that	NULL
is	NULL
analogous	NULL
to	NULL
that	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
in	NULL
most	NULL
RNA	NULL
polymerase	NULL
II-transcribed	NULL
genes	NULL
.	NULL

Interaction	NULL
of	NULL
BSAP	NULL
with	NULL
the	NULL
two	NULL
sites	NULL
in	NULL
the	NULL
CD19	NULL
promoter	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
BSAP	NULL
with	NULL
its	NULL
two	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
CD19	NULL
promoter	NULL
was	NULL
analyzed	NULL
in	NULL
more	NULL
detail	NULL
by	NULL
bandshift	NULL
assay	NULL
and	NULL
methylation	NULL
interference	NULL
analysis	NULL
.	NULL

End-labeled	NULL
oligonucleotides	NULL
containing	NULL
these	NULL
two	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
detect	NULL
only	NULL
BSAP	NULL
in	NULL
unfractionated	NULL
nuclear	NULL
extracts	NULL
of	NULL
BJA-B	NULL
cells	NULL
,	NULL
as	NULL
the	NULL
complex	NULL
formed	NULL
can	NULL
be	NULL
specifically	NULL
competed	NULL
for	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
a	NULL
sea	NULL
urchin	NULL
TSAP-binding	NULL
site	NULL
but	NULL
not	NULL
with	NULL
the	NULL
unrelated	NULL
recognition	NULL
sequence	NULL
of	NULL
the	NULL
PU.1	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
close	NULL
contact	NULL
sites	NULL
of	NULL
BSAP	NULL
within	NULL
the	NULL
two	NULL
recognition	NULL
sequences	NULL
were	NULL
mapped	NULL
by	NULL
methylation	NULL
interference	NULL
analysis	NULL
(	NULL
32	NULL
)	NULL
,	NULL
the	NULL
result	NULL
of	NULL
which	NULL
is	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
.	NULL

Four	NULL
interfering	NULL
G	NULL
residues	NULL
are	NULL
present	NULL
in	NULL
analogous	NULL
positions	NULL
within	NULL
both	NULL
recognition	NULL
sequences	NULL
,	NULL
suggesting	NULL
correct	NULL
alignment	NULL
of	NULL
both	NULL
BSAP	NULL
sites	NULL
with	NULL
each	NULL
other	NULL
in	NULL
the	NULL
same	NULL
orientation	NULL
as	NULL
they	NULL
occur	NULL
in	NULL
the	NULL
CD19	NULL
promoter	NULL
(	NULL
see	NULL
also	NULL
Discussion	NULL
)	NULL
.	NULL

BSAP	NULL
is	NULL
the	NULL
only	NULL
abundant	NULL
factor	NULL
interacting	NULL
with	NULL
the	NULL
human	NULL
CD19	NULL
promoter	NULL
in	NULL
unfractionated	NULL
B-cell	NULL
extracts	NULL
.	NULL

So	NULL
far	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
only	NULL
the	NULL
interaction	NULL
of	NULL
purified	NULL
BSAP	NULL
with	NULL
the	NULL
CD19	NULL
gene	NULL
.	NULL

Using	NULL
unfractionated	NULL
extracts	NULL
of	NULL
B-lymphoid	NULL
and	NULL
HeLa	NULL
cells	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
whether	NULL
other	NULL
nuclear	NULL
factors	NULL
also	NULL
bind	NULL
to	NULL
the	NULL
CD19	NULL
promoter	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
an	NULL
unfractionated	NULL
BJA-B	NULL
extract	NULL
generated	NULL
the	NULL
2668	NULL
KOZMIK	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
B	NULL
{	NULL
-	NULL
o.	NULL
c	NULL
as	NULL
C	NULL
A	NULL
<	NULL
¢	NULL
f	NULL
<	NULL
k7g3	NULL
,	NULL
co	NULL
I	NULL
O	NULL
+	NULL
-	NULL
-	NULL
--	NULL
comp	NULL
BSAP	NULL
site	NULL
2	NULL
|	NULL
I	NULL
Z	NULL
site	NULL
1	NULL
i	NULL
coding	NULL
strand	NULL
|	NULL
no	NULL
XT	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

&	NULL
C	NULL
QU	NULL
C	NULL
®	NULL
o	NULL
.	NULL

-	NULL
o	NULL
s	NULL
I-	NULL
o	NULL
.	NULL

3	NULL
§	NULL
45°C	NULL
&	NULL
<	NULL
<	NULL
x	NULL
<	NULL
o	NULL
Q	NULL
<	NULL
€	NULL
Wo	NULL
-G	NULL
GG	NULL
i	NULL
-o	NULL
-t	NULL
IC	NULL
(	NULL
C	NULL
C	NULL
C	NULL
m	NULL
f	NULL
0	NULL
-c.	NULL
o	NULL
BSAP	NULL
|	NULL
site	NULL
2	NULL
,	NULL
non-coding	NULL
strand	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

In	NULL
vitro	NULL
footprint	NULL
of	NULL
the	NULL
CD19	NULL
promoter	NULL
in	NULL
unfractionated	NULL
nuclear	NULL
extracts	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DNase	NULL
I	NULL
footprint	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
promoter	NULL
.	NULL

The	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
was	NULL
3	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
a	NULL
Sauw3A	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
,	NULL
and	NULL
this	NULL
DNA	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
either	NULL
partially	NULL
purified	NULL
BSAP	NULL
protein	NULL
or	NULL
unfractionated	NULL
nuclear	NULL
extracts	NULL
of	NULL
BJA-B	NULL
and	NULL
HeLa	NULL
cells	NULL
prior	NULL
to	NULL
DNase	NULL
I	NULL
digestion	NULL
and	NULL
electrophoresis	NULL
on	NULL
an	NULL
8	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
TSAP-binding	NULL
site	NULL
of	NULL
the	NULL
H2A-2.2	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
a	NULL
specific	NULL
competitor	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
DNase	NULL
I	NULL
protection	NULL
is	NULL
indicated	NULL
by	NULL
brackets	NULL
.	NULL

Lane	NULL
no	NULL
XT	NULL
,	NULL
control	NULL
DNase	NULL
I	NULL
digestion	NULL
of	NULL
naked	NULL
DNA	NULL
;	NULL
lane	NULL
G+	NULL
A	NULL
,	NULL
Maxam-Gilbert	NULL
(	NULL
21	NULL
)	NULL
sequencing	NULL
ladder	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DMS	NULL
protection	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
promoter	NULL
.	NULL

The	NULL
DNA	NULL
probe	NULL
was	NULL
3	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
a	NULL
HpaII	NULL
site	NULL
in	NULL
the	NULL
transcription	NULL
initiation	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
promoter	NULL
,	NULL
incubated	NULL
in	NULL
unfractionated	NULL
nuclear	NULL
extracts	NULL
,	NULL
briefly	NULL
exposed	NULL
to	NULL
DMS	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
chemical	NULL
cleavage	NULL
at	NULL
methylated	NULL
G	NULL
residues	NULL
and	NULL
separation	NULL
on	NULL
a	NULL
denaturing	NULL
8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Black	NULL
arrowheads	NULL
point	NULL
to	NULL
protected	NULL
G	NULL
residues	NULL
;	NULL
open	NULL
arrowheads	NULL
indicate	NULL
hyperreactive	NULL
guanosines	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNase	NULL
I	NULL
footprint	NULL
of	NULL
the	NULL
mouse	NULL
CD19	NULL
promoter	NULL
.	NULL

The	NULL
DNA	NULL
probe	NULL
was	NULL
3	NULL
'	NULL
end	NULL
labeled	NULL
at	NULL
a	NULL
BamHI	NULL
site	NULL
which	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
first	NULL
exon	NULL
by	NULL
PCR	NULL
cloning	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
putative	NULL
positions	NULL
of	NULL
BSAP	NULL
site	NULL
2	NULL
and	NULL
the	NULL
transcription	NULL
initiation	NULL
region	NULL
in	NULL
analogy	NULL
to	NULL
the	NULL
human	NULL
CD19	NULL
promoter	NULL
are	NULL
indicated	NULL
by	NULL
dashed	NULL
lines	NULL
.	NULL

same	NULL
DNase	NULL
I	NULL
footprint	NULL
pattern	NULL
on	NULL
the	NULL
CD19	NULL
promoter	NULL
as	NULL
did	NULL
purified	NULL
BSAP	NULL
protein	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
BSAP	NULL
is	NULL
the	NULL
only	NULL
abundant	NULL
DNA-binding	NULL
protein	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
the	NULL
proximal	NULL
promoter	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
in	NULL
BJA-B	NULL
cells	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
methylation	NULL
protection	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
.	NULL

An	NULL
end-labeled	NULL
CD19	NULL
promoter	NULL
fragment	NULL
was	NULL
incubated	NULL
in	NULL
different	NULL
nuclear	NULL
extracts	NULL
,	NULL
briefly	NULL
exposed	NULL
to	NULL
DMS	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
cleavage	NULL
at	NULL
methylated	NULL
G	NULL
residues	NULL
and	NULL
to	NULL
electrophoretic	NULL
analysis	NULL
.	NULL

Specific	NULL
G	NULL
residues	NULL
within	NULL
BSAP	NULL
sites	NULL
1	NULL
and	NULL
2	NULL
were	NULL
protected	NULL
from	NULL
methylation	NULL
only	NULL
by	NULL
three	NULL
BSAP-positive	NULL
extracts	NULL
(	NULL
Raji	NULL
,	NULL
REH	NULL
,	NULL
and	NULL
BJA-B	NULL
)	NULL
and	NULL
by	NULL
the	NULL
purified	NULL
BSAP	NULL
protein	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
same	NULL
G	NULL
residues	NULL
prevented	NULL
BSAP	NULL
binding	NULL
in	NULL
the	NULL
methylation	NULL
interference	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

No	NULL
G	NULL
residues	NULL
outside	NULL
of	NULL
the	NULL
two	NULL
BSAP	NULL
sites	NULL
were	NULL
protected	NULL
,	NULL
while	NULL
two	NULL
guanines	NULL
were	NULL
hyperreactive	NULL
in	NULL
BSAP-positive	NULL
nuclear	NULL
extracts	NULL
for	NULL
unknown	NULL
reasons	NULL
.	NULL

The	NULL
control	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
contains	NULL
an	NULL
activity	NULL
that	NULL
also	NULL
bound	NULL
to	NULL
the	NULL
BSAP	NULL
site	NULL
2	NULL
sequence	NULL
but	NULL
generated	NULL
a	NULL
DNase	NULL
I	NULL
footprint	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
BSAP	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

This	NULL
activity	NULL
was	NULL
not	NULL
further	NULL
characterized	NULL
and	NULL
could	NULL
not	NULL
even	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
DMS	NULL
protection	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
possibly	NULL
because	NULL
of	NULL
differences	NULL
in	NULL
the	NULL
binding	NULL
condition	NULL
of	NULL
the	NULL
two	NULL
assays	NULL
.	NULL

A	NULL
DNA	NULL
fragment	NULL
spanning	NULL
the	NULL
first	NULL
200	NULL
bp	NULL
of	NULL
the	NULL
CD19	NULL
promoter	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
for	NULL
bandshift	NULL
experiments	NULL
with	NULL
BJA-B	NULL
nuclear	NULL
extracts	NULL
.	NULL

Again	NULL
no	NULL
specific	NULL
DNA-binding	NULL
activity	NULL
other	NULL
than	NULL
BSAP	NULL
was	NULL
identified	NULL
by	NULL
this	NULL
method	NULL
(	NULL
15a	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
conclude	NULL
that	NULL
BSAP	NULL
is	NULL
the	NULL
only	NULL
abundant	NULL
DNA-binding	NULL
protein	NULL
that	NULL
interacts	NULL
in	NULL
vitro	NULL
with	NULL
the	NULL
proximal	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
.	NULL

Evolutionary	NULL
conservation	NULL
of	NULL
BSAP	NULL
site	NULL
1	NULL
.	NULL

The	NULL
mouse	NULL
CD19	NULL
promoter	NULL
was	NULL
cloned	NULL
by	NULL
a	NULL
genomic	NULL
walking	NULL
technique	NULL
(	NULL
9	NULL
)	NULL
which	NULL
is	NULL
based	NULL
on	NULL
the	NULL
ligation-mediated	NULL
PCR	NULL
method	NULL
previously	NULL
developed	NULL
for	NULL
in	NULL
vivo	NULL
footprinting	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
only	NULL
information	NULL
required	NULL
for	NULL
this	NULL
cloning	NULL
procedure	NULL
was	NULL
the	NULL
mouse	NULL
CD19	NULL
full-length	NULL
cDNA	NULL
sequence	NULL
(	NULL
38	NULL
)	NULL
,	NULL
allowing	NULL
the	NULL
Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
s	NULL
3	NULL
o	NULL
63	NULL
8	NULL
D	NULL
y	NULL
E	NULL
a	NULL
<	NULL
(	NULL
.	NULL

f	NULL
+	NULL
§	NULL
=	NULL
2	NULL
&	NULL
S	NULL
o	NULL
©	NULL
.C	NULL
.m	NULL
«	NULL
w	NULL
A	NULL
\|	NULL
z	NULL
m	NULL
*s	NULL
soam	NULL
l	NULL
p	NULL
®	NULL
S	NULL
3	NULL
<	NULL
c	NULL
a	NULL
.	NULL

=3	NULL
I	NULL
CC	NULL
c	NULL
CBD	NULL
sm	NULL
ses	NULL
--	NULL
mre	NULL
/	NULL
P	NULL
|-	NULL
Sites	NULL
.	NULL

--	NULL
Se	NULL
_	NULL
,	NULL
5	NULL
<	NULL
i	NULL
Hl	NULL
wns	NULL
_	NULL
$	NULL
e	NULL
wwe	NULL
somc	NULL
tom	NULL
came	NULL
esen	NULL
4	NULL
\	NULL
8	NULL
--	NULL
-	NULL
tine	NULL
eme	NULL
ms	NULL
a	NULL
©	NULL
SB	NULL
some	NULL
mome	NULL
meow	NULL
mame	NULL
-|	NULL
_	NULL
.	NULL

'-——	NULL
wie	NULL
non-	NULL
coding	NULL
strand	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

In	NULL
vivo	NULL
footprint	NULL
of	NULL
the	NULL
CD19	NULL
promoter	NULL
.	NULL

Intact	NULL
BJA-B	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
RPMI	NULL
8226	NULL
cells	NULL
or	NULL
naked	NULL
DNA	NULL
isolated	NULL
from	NULL
BJA-B	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
DMS	NULL
,	NULL
and	NULL
DNA	NULL
was	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
chemical	NULL
cleavage	NULL
at	NULL
methylated	NULL
G	NULL
residues	NULL
,	NULL
linker	NULL
liga-tion	NULL
,	NULL
and	NULL
PCR	NULL
amplification	NULL
as	NULL
described	NULL
by	NULL
Mueller	NULL
and	NULL
Wold	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
CD19	NULL
gene-specific	NULL
primers	NULL
used	NULL
for	NULL
PCR	NULL
are	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Control	NULL
sequence	NULL
ladders	NULL
were	NULL
generated	NULL
by	NULL
genomic	NULL
sequencing	NULL
of	NULL
naked	NULL
BJA-B	NULL
DNA	NULL
following	NULL
depurina-tion	NULL
with	NULL
formic	NULL
acid	NULL
(	NULL
lane	NULL
G+A	NULL
)	NULL
or	NULL
modification	NULL
with	NULL
hydrazine	NULL
(	NULL
lane	NULL
C	NULL
)	NULL
.	NULL

design	NULL
of	NULL
5'-terminal	NULL
,	NULL
CD19-specific	NULL
primers	NULL
.	NULL

The	NULL
mouse	NULL
promoter	NULL
was	NULL
isolated	NULL
as	NULL
a	NULL
670-bp	NULL
PCR	NULL
fragment	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

DNA	NULL
sequence	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
BSAP-binding	NULL
site	NULL
1	NULL
has	NULL
been	NULL
relatively	NULL
well	NULL
conserved	NULL
between	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
CD19	NULL
promoters	NULL
,	NULL
as	NULL
only	NULL
4	NULL
of	NULL
26	NULL
nucleotide	NULL
positions	NULL
differ	NULL
by	NULL
point	NULL
mutation	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
insertion	NULL
of	NULL
six	NULL
nucleotides	NULL
was	NULL
found	NULL
in	NULL
the	NULL
putative	NULL
BSAP	NULL
site	NULL
2	NULL
of	NULL
the	NULL
mouse	NULL
promoter	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
finding	NULL
,	NULL
purified	NULL
BSAP	NULL
bound	NULL
only	NULL
to	NULL
site	NULL
1	NULL
of	NULL
the	NULL
mouse	NULL
promoter	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
DNase	NULL
I	NULL
footprint	NULL
experiment	NULL
of	NULL
Fig	NULL
.	NULL

6C	NULL
.	NULL

Bandshift	NULL
competition	NULL
experiments	NULL
furthermore	NULL
demonstrated	NULL
that	NULL
BSAP	NULL
binds	NULL
to	NULL
both	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
BSAP	NULL
site	NULL
1	NULL
with	NULL
the	NULL
same	NULL
high	NULL
affinity	NULL
(	NULL
152	NULL
)	NULL
.	NULL

BSAP	NULL
binds	NULL
in	NULL
vivo	NULL
to	NULL
its	NULL
high-affinity	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
CD19	NULL
promoter	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
BSAP	NULL
with	NULL
the	NULL
CD19	NULL
promoter	NULL
was	NULL
next	NULL
investigated	NULL
by	NULL
in	NULL
vivo	NULL
footprinting	NULL
using	NULL
the	NULL
ligation-mediated	NULL
PCR	NULL
method	NULL
described	NULL
by	NULL
Mueller	NULL
and	NULL
Wold	NULL
(	NULL
22	NULL
)	NULL
.	NULL

BJA-B	NULL
,	NULL
RPMI	NULL
8226	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
briefly	NULL
exposed	NULL
to	NULL
DMS	NULL
,	NULL
and	NULL
genomic	NULL
DNA	NULL
was	NULL
isolated	NULL
and	NULL
cleaved	NULL
at	NULL
methylated	NULL
G	NULL
residues	NULL
.	NULL

After	NULL
complementary	NULL
strand	NULL
synthesis	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
subjected	NULL
to	NULL
linker	NULL
ligation	NULL
and	NULL
exponential	NULL
amplification	NULL
of	NULL
CD19	NULL
promoter	NULL
sequences	NULL
with	NULL
specific	NULL
oligonucleotides	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Figure	NULL
7	NULL
demonstrates	NULL
that	NULL
exactly	NULL
the	NULL
same	NULL
methylation	NULL
protection	NULL
pattern	NULL
is	NULL
observed	NULL
for	NULL
BSAP	NULL
site	NULL
1	NULL
in	NULL
BJA-B	NULL
cells	NULL
in	NULL
vivo	NULL
as	NULL
is	NULL
seen	NULL
with	NULL
nuclear	NULL
extracts	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
two	NULL
G	NULL
residues	NULL
in	NULL
the	NULL
middle	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
region	NULL
are	NULL
partially	NULL
protected	NULL
.	NULL

There	NULL
is	NULL
,	NULL
however	NULL
,	NULL
no	NULL
evidence	NULL
for	NULL
an	NULL
in	NULL
vivo	NULL
interaction	NULL
of	NULL
BSAP	NULL
with	NULL
the	NULL
distal	NULL
site	NULL
2	NULL
in	NULL
BJA-B	NULL
cells	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

6B	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
no	NULL
protection	NULL
of	NULL
site	NULL
1	NULL
is	NULL
seen	NULL
in	NULL
the	NULL
BSAP	NULL
REGULATION	NULL
OF	NULL
THE	NULL
CD19	NULL
GENE	NULL
BY	NULL
BSAP	NULL
2669	NULL
J558L	NULL
-	NULL
SP2/0	NULL
Co	NULL
Co	NULL
10	NULL
6	NULL
o	NULL
so	NULL
so	NULL
.	NULL

m	NULL
td	NULL
-	NULL
130	NULL
BJA-B	NULL
z	NULL
5	NULL
end	NULL
-	NULL
wwe	NULL
relerencer	NULL
mad	NULL
-	NULL
117	NULL
sv4o	NULL
TATA	NULL
B-globin	NULL
enhancer	NULL
P	NULL
AAAE	NULL
,	NULL
oveo-s	NULL
J	NULL
--	NULL
L	NULL
--	NULL
-	NULL
GTT	NULL
BSAP	NULL
site	NULL
_	NULL
mamaaa	NULL
»	NULL
|	NULL
j	NULL
ovec-cors	NULL
-e	NULL
Ms	NULL
CT	NULL
777	NULL
uo	NULL
ovec-Ret	NULL
FP	NULL
f-	NULL
del	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Evidence	NULL
that	NULL
the	NULL
BSAP-binding	NULL
site	NULL
1	NULL
is	NULL
a	NULL
functional	NULL
promoter	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
test	NULL
plasmids	NULL
OVEC-S	NULL
and	NULL
OVEC-CD19	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
BJA-B	NULL
,	NULL
J558L	NULL
,	NULL
and	NULL
SP2/0	NULL
cells	NULL
together	NULL
with	NULL
OVEC-Ref	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
B-globin	NULL
reporter	NULL
gene	NULL
was	NULL
analyzed	NULL
by	NULL
SP6	NULL
mapping	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

BJA-B	NULL
is	NULL
a	NULL
human	NULL
B-cell	NULL
line	NULL
;	NULL
J558L	NULL
and	NULL
$	NULL
P2/0	NULL
are	NULL
two	NULL
mouse	NULL
plasma	NULL
cell	NULL
lines	NULL
.	NULL

OVEC-S	NULL
and	NULL
OVEC-Ref	NULL
were	NULL
described	NULL
by	NULL
Westin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
.	NULL

OVEC-CD19	NULL
contains	NULL
the	NULL
BSAP	NULL
site	NULL
1	NULL
oligonucleotide	NULL
(	NULL
flanked	NULL
by	NULL
Sa/l	NULL
ends	NULL
;	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
in	NULL
the	NULL
Saf	NULL
site	NULL
of	NULL
OVEC-S.	NULL
5	NULL
'	NULL
end	NULL
indicates	NULL
the	NULL
correctly	NULL
initiated	NULL
B-globin	NULL
transcripts	NULL
of	NULL
the	NULL
test	NULL
plasmids	NULL
;	NULL
reference	NULL
indicates	NULL
transcripts	NULL
of	NULL
plasmid	NULL
OVEC-Ref	NULL
.	NULL

5'-end-labeled	NULL
pUC18	NULL
DNA	NULL
digested	NULL
with	NULL
MspI	NULL
was	NULL
used	NULL
as	NULL
a	NULL
size	NULL
marker	NULL
(	NULL
lane	NULL
M	NULL
;	NULL
sizes	NULL
given	NULL
in	NULL
nucleotides	NULL
)	NULL
.	NULL

negative	NULL
RPMI	NULL
8226	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
proximal	NULL
high-affinity	NULL
site	NULL
of	NULL
the	NULL
CD19	NULL
promoter	NULL
is	NULL
fully	NULL
occupied	NULL
in	NULL
vivo	NULL
by	NULL
BSAP	NULL
in	NULL
a	NULL
CD19-expressing	NULL
B-cell	NULL
line	NULL
.	NULL

BSAP	NULL
site	NULL
1	NULL
is	NULL
a	NULL
functional	NULL
promoter	NULL
element	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
evolutionary	NULL
conservation	NULL
and	NULL
the	NULL
in	NULL
vivo	NULL
footprint	NULL
experiment	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
high-affinity	NULL
BSAP	NULL
site	NULL
1	NULL
is	NULL
a	NULL
functional	NULL
promoter	NULL
element	NULL
.	NULL

We	NULL
have	NULL
tested	NULL
this	NULL
supposition	NULL
by	NULL
the	NULL
transient	NULL
transfection	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
BSAP	NULL
site	NULL
1	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
rabbit	NULL
B-globin	NULL
gene	NULL
in	NULL
the	NULL
vector	NULL
OVEC-S	NULL
(	NULL
37	NULL
)	NULL
.	NULL

This	NULL
test	NULL
plasmid	NULL
and	NULL
the	NULL
parental	NULL
vector	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
B-cell	NULL
line	NULL
BJA-B	NULL
and	NULL
the	NULL
two	NULL
plasma	NULL
cell	NULL
lines	NULL
J558L	NULL
and	NULL
SP2/0	NULL
together	NULL
with	NULL
a	NULL
reference	NULL
gene	NULL
containing	NULL
a	NULL
deletion	NULL
in	NULL
the	NULL
B-globin	NULL
leader	NULL
sequence	NULL
(	NULL
OVEC-Ref	NULL
[	NULL
37	NULL
]	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
was	NULL
isolated	NULL
48	NULL
h	NULL
later	NULL
,	NULL
and	NULL
transcripts	NULL
of	NULL
both	NULL
the	NULL
test	NULL
and	NULL
reference	NULL
genes	NULL
were	NULL
mapped	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

The	NULL
BSAP	NULL
site	NULL
1	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
clearly	NULL
functions	NULL
as	NULL
an	NULL
efficient	NULL
promoter	NULL
element	NULL
to	NULL
stimulate	NULL
B-globin	NULL
gene	NULL
transcription	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
plasma	NULL
cells	NULL
.	NULL

A	NULL
similar	NULL
experiment	NULL
previously	NULL
demonstrated	NULL
that	NULL
the	NULL
TSAP-binding	NULL
site	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
H2A-2.2	NULL
gene	NULL
confers	NULL
B-cell	NULL
specificity	NULL
to	NULL
the	NULL
same	NULL
B-globin	NULL
reporter	NULL
gene	NULL
(	NULL
3	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
conclude	NULL
that	NULL
the	NULL
BSAP	NULL
site	NULL
1	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
is	NULL
not	NULL
only	NULL
biochemically	NULL
equivalent	NULL
but	NULL
also	NULL
functionally	NULL
similar	NULL
to	NULL
the	NULL
sea	NULL
urchin	NULL
TSAP-binding	NULL
site	NULL
.	NULL

DISCUSSION	NULL
The	NULL
B-cell-specific	NULL
transcription	NULL
factor	NULL
BSAP	NULL
was	NULL
previously	NULL
identified	NULL
as	NULL
a	NULL
mammalian	NULL
homolog	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
2670	NULL
KOZMIK	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

BSAP	NULL
site	NULL
2	NULL
in	NULL
vitro	NULL
binding	NULL
(	NULL
M	NULL
)	NULL
'out	NULL
A_	NULL
Y	NULL
T	NULL
|	NULL
human	NULL
-	NULL
CAGCGTGGCAGGGAGGAGGCAAGTGTTGTGAGTCTGGAGGGTTCCTGGAGAATGGGGCCTGAGGCGTGACCACCGCCTTCCTCTCTGGGGGGACTGCCTEC	NULL
mouse	NULL
-	NULL
--	NULL
A	NULL
6—1	NULL
GA	NULL
-T	NULL
A-AG-G-CT-CA	NULL
--	NULL
A-|-	NULL
A-	NULL
T	NULL
C-T	NULL
A-AC	NULL
A-A	NULL
GCCTAA	NULL
BSAP	NULL
site	NULL
1	NULL
5°	NULL
ends	NULL
of	NULL
CD19	NULL
mRNA	NULL
e	NULL
e	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
binding	NULL
(	NULL
H	NULL
)	NULL
¥	NULL
T	NULL
TCC	NULL
OOF	NULL
0000	NULL
|	NULL
Mo	NULL
P	NULL
P	NULL
P	NULL
R	NULL
A	NULL
__	NULL
YV	NULL
HL	NULL
HH	NULL
OJ	NULL
OLE	NULL
__	NULL
IHH	NULL
4	NULL
|	NULL
CGCCCCCGCAGACACCCATGGTTGAGTGCCCTCCAGGCCCCTGCCTGCCCCAGCATCCCCTGCGCGAAGCTGGGTGCCCCGGAGAGTCTGACCACCATGCCACCTCCTCGC	NULL
~A	NULL
-	NULL
T-A	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-G-T	NULL
--	NULL
-A-T	NULL
--	NULL
T	NULL
TC	NULL
T	NULL
c	NULL
A-	NULL
&	NULL
-C-	NULL
@	NULL
-T	NULL
--	NULL
--	NULL
-1T	NULL
--	NULL
-	NULL
T-AGCCACGCA	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Promoter	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
CD19	NULL
genes	NULL
and	NULL
summary	NULL
of	NULL
protein-DNA	NULL
interactions	NULL
.	NULL

Only	NULL
the	NULL
nucleotides	NULL
that	NULL
differ	NULL
from	NULL
the	NULL
human	NULL
CD19	NULL
sequence	NULL
are	NULL
shown	NULL
for	NULL
the	NULL
mouse	NULL
promoter	NULL
.	NULL

The	NULL
data	NULL
of	NULL
the	NULL
DNase	NULL
I	NULL
footprint	NULL
and	NULL
methylation	NULL
interference	NULL
analyses	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
symbols	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Dots	NULL
denote	NULL
the	NULL
G	NULL
residues	NULL
that	NULL
are	NULL
either	NULL
protected	NULL
or	NULL
hyperreactive	NULL
in	NULL
the	NULL
in	NULL
vivo	NULL
footprint	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Transcription	NULL
initiation	NULL
sites	NULL
(	NULL
mapped	NULL
by	NULL
S1	NULL
nuclease	NULL
analysis	NULL
;	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
are	NULL
shown	NULL
by	NULL
short	NULL
vertical	NULL
lines	NULL
.	NULL

M	NULL
and	NULL
H	NULL
denote	NULL
medium-	NULL
and	NULL
high-affinity	NULL
binding	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

protein	NULL
TSAP	NULL
.	NULL

Competition	NULL
experiments	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
high-affinity	NULL
BSAP-binding	NULL
site	NULL
in	NULL
known	NULL
regulatory	NULL
regions	NULL
of	NULL
immunoglobulin	NULL
and	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
complex	NULL
genes	NULL
,	NULL
suggesting	NULL
that	NULL
BSAP	NULL
may	NULL
regulate	NULL
a	NULL
different	NULL
set	NULL
of	NULL
B-lymphoid-specific	NULL
genes	NULL
(	NULL
3	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
.	NULL

Five	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
BSAP	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

First	NULL
,	NULL
complete	NULL
correlation	NULL
was	NULL
observed	NULL
between	NULL
CD19	NULL
gene	NULL
expression	NULL
and	NULL
BSAP	NULL
activity	NULL
in	NULL
a	NULL
large	NULL
panel	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
B-lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Second	NULL
,	NULL
a	NULL
high-affinity	NULL
BSAP-binding	NULL
site	NULL
was	NULL
found	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
sites	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
.	NULL

Third	NULL
,	NULL
this	NULL
high-affinity	NULL
binding	NULL
site	NULL
has	NULL
been	NULL
evolu-tionarily	NULL
conserved	NULL
between	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
CD19	NULL
promoters	NULL
.	NULL

Fourth	NULL
,	NULL
in	NULL
vivo	NULL
footprinting	NULL
demonstrated	NULL
that	NULL
this	NULL
site	NULL
is	NULL
fully	NULL
occupied	NULL
by	NULL
BSAP	NULL
in	NULL
a	NULL
CD19-expressing	NULL
B-cell	NULL
line	NULL
but	NULL
not	NULL
in	NULL
nonexpressing	NULL
cells	NULL
.	NULL

Fifth	NULL
,	NULL
this	NULL
high-affinity	NULL
BSAP	NULL
site	NULL
was	NULL
shown	NULL
to	NULL
function	NULL
as	NULL
an	NULL
efficient	NULL
promoter	NULL
element	NULL
in	NULL
transiently	NULL
transfected	NULL
B	NULL
cells	NULL
.	NULL

Figure	NULL
9	NULL
summarizes	NULL
the	NULL
results	NULL
of	NULL
our	NULL
CD19	NULL
promoter	NULL
analyses	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
gene	NULL
starts	NULL
at	NULL
multiple	NULL
sites	NULL
within	NULL
a	NULL
40-bp	NULL
G+C-rich	NULL
sequence	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
three	NULL
different	NULL
methods	NULL
.	NULL

A	NULL
very	NULL
similar	NULL
situation	NULL
has	NULL
been	NULL
described	NULL
for	NULL
another	NULL
B-cell-specific	NULL
gene	NULL
coding	NULL
for	NULL
the	NULL
B29	NULL
protein	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Such	NULL
heterogeneity	NULL
of	NULL
mRNA	NULL
5	NULL
'	NULL
ends	NULL
is	NULL
normally	NULL
observed	NULL
with	NULL
genes	NULL
that	NULL
lack	NULL
a	NULL
canonical	NULL
TATA	NULL
box	NULL
in	NULL
their	NULL
-30	NULL
promoter	NULL
regions	NULL
(	NULL
4	NULL
,	NULL
12	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
finding	NULL
,	NULL
there	NULL
is	NULL
no	NULL
TATA-like	NULL
sequence	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
.	NULL

The	NULL
high-affinity	NULL
site	NULL
1	NULL
which	NULL
is	NULL
bound	NULL
by	NULL
BSAP	NULL
in	NULL
vivo	NULL
is	NULL
instead	NULL
located	NULL
in	NULL
the	NULL
-30	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
a	NULL
BSAP-binding	NULL
site	NULL
cooperates	NULL
with	NULL
a	NULL
TATA	NULL
element	NULL
to	NULL
bring	NULL
about	NULL
efficient	NULL
transcription	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
transiently	NULL
transfected	NULL
B	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
location	NULL
of	NULL
BSAP	NULL
site	NULL
1	NULL
in	NULL
the	NULL
CD19	NULL
promoter	NULL
now	NULL
suggests	NULL
that	NULL
BSAP	NULL
,	NULL
like	NULL
Spl	NULL
(	NULL
28	NULL
)	NULL
and	NULL
GCN4	NULL
(	NULL
6	NULL
)	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
the	NULL
transcription	NULL
machinery	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
TATA	NULL
box	NULL
.	NULL

BSAP	NULL
is	NULL
the	NULL
only	NULL
abundant	NULL
DNA-binding	NULL
activity	NULL
present	NULL
in	NULL
B-cell	NULL
nuclear	NULL
extracts	NULL
that	NULL
could	NULL
be	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
first	NULL
200	NULL
bp	NULL
of	NULL
the	NULL
CD19	NULL
promoter	NULL
by	NULL
in	NULL
vitro	NULL
protein-DNA	NULL
binding	NULL
studies	NULL
.	NULL

The	NULL
human	NULL
CD19	NULL
promoter	NULL
contains	NULL
a	NULL
second	NULL
BSAP-binding	NULL
site	NULL
of	NULL
lower	NULL
affinity	NULL
which	NULL
is	NULL
located	NULL
35	NULL
bp	NULL
upstream	NULL
of	NULL
site	NULL
1	NULL
.	NULL

However	NULL
,	NULL
no	NULL
evidence	NULL
for	NULL
an	NULL
interaction	NULL
of	NULL
BSAP	NULL
with	NULL
this	NULL
site	NULL
in	NULL
vivo	NULL
was	NULL
obtained	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
second	NULL
binding	NULL
site	NULL
has	NULL
been	NULL
eliminated	NULL
from	NULL
the	NULL
mouse	NULL
CD19	NULL
promoter	NULL
by	NULL
insertion	NULL
of	NULL
six	NULL
nucleotides	NULL
into	NULL
the	NULL
corresponding	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
and	NULL
9	NULL
)	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
likely	NULL
that	NULL
the	NULL
second	NULL
BSAP-binding	NULL
site	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
promoter	NULL
plays	NULL
only	NULL
a	NULL
minor	NULL
role	NULL
,	NULL
if	NULL
any	NULL
,	NULL
in	NULL
CD19	NULL
gene	NULL
transcription	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
DNA	NULL
sequence	NULL
recognition	NULL
of	NULL
BSAP	NULL
is	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
transcription	NULL
factor	NULL
TSAP	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Only	NULL
a	NULL
degenerate	NULL
consensus	NULL
sequence	NULL
for	NULL
TSAP	NULL
could	NULL
be	NULL
deduced	NULL
from	NULL
four	NULL
high-affinity	NULL
binding	NULL
sites	NULL
of	NULL
sea	NULL
urchin	NULL
histone	NULL
genes	NULL
,	NULL
and	NULL
comparison	NULL
of	NULL
three	NULL
different	NULL
parameters	NULL
(	NULL
primary	NULL
sequence	NULL
,	NULL
DNase	NULL
I	NULL
foot-print	NULL
,	NULL
and	NULL
methylation	NULL
interference	NULL
pattern	NULL
)	NULL
was	NULL
required	NULL
for	NULL
correct	NULL
alignment	NULL
of	NULL
all	NULL
four	NULL
sequences	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
same	NULL
three	NULL
parameters	NULL
for	NULL
BSAP	NULL
sites	NULL
1	NULL
and	NULL
2	NULL
of	NULL
the	NULL
human	NULL
CD19	NULL
promoter	NULL
resulted	NULL
in	NULL
the	NULL
best	NULL
alignment	NULL
with	NULL
the	NULL
TSAP	NULL
consensus	NULL
sequence	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

A	NULL
gap	NULL
of	NULL
one	NULL
nucleotide	NULL
had	NULL
to	NULL
be	NULL
introduced	NULL
into	NULL
site	NULL
2	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
its	NULL
lower	NULL
affinity	NULL
for	NULL
BSAP	NULL
.	NULL

Preliminary	NULL
mutational	NULL
analysis	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
alignment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
.	NULL

A	NULL
C-to-A	NULL
mutation	NULL
at	NULL
the	NULL
position	NULL
corresponding	NULL
to	NULL
the	NULL
only	NULL
strictly	NULL
invariant	NULL
C	NULL
residue	NULL
of	NULL
the	NULL
TSAP	NULL
consensus	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
reduces	NULL
the	NULL
affinity	NULL
of	NULL
BSAP	NULL
site	NULL
1	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
5	NULL
,	NULL
while	NULL
insertion	NULL
of	NULL
an	NULL
A	NULL
residue	NULL
eliminating	NULL
the	NULL
gap	NULL
in	NULL
site	NULL
2	NULL
creates	NULL
a	NULL
high-affinity	NULL
binding	NULL
site	NULL
(	NULL
15a	NULL
)	NULL
.	NULL

The	NULL
high-affinity	NULL
site	NULL
1	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
functions	NULL
as	NULL
an	NULL
TSAP	NULL
consensus	NULL
-	NULL
-	NULL
-	NULL
GACaCca-	NULL
--	NULL
BSAP	NULL
site	NULL
1	NULL
(	NULL
m	NULL
)	NULL
-	NULL
A	NULL
G	NULL
A	NULL
CWR	NULL
c	NULL
#	NULL
Tica	NULL
ta	NULL
BSAP	NULL
site	NULL
1	NULL
(	NULL
h	NULL
)	NULL
-	NULL
A	NULL
G	NULL
A	NULL
eB	NULL
tat	NULL
aclictcca	NULL
BSAP	NULL
site	NULL
2	NULL
(	NULL
h	NULL
)	NULL
_	NULL
A	NULL
A	NULL
T	NULL
He	NULL
c	NULL
@	NULL
iiiec	NULL
MRR	NULL
cate	NULL
ce	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
BSAP	NULL
recognition	NULL
sequences	NULL
of	NULL
the	NULL
CD19	NULL
promoter	NULL
BSAP-binding	NULL
sites	NULL
1	NULL
and	NULL
2	NULL
of	NULL
the	NULL
human	NULL
(	NULL
h	NULL
)	NULL
CD19	NULL
promoters	NULL
and	NULL
site	NULL
1	NULL
of	NULL
the	NULL
mouse	NULL
(	NULL
m	NULL
)	NULL
promoter	NULL
were	NULL
aligned	NULL
with	NULL
the	NULL
previously	NULL
deduced	NULL
consensus	NULL
sequence	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
TSAP-binding	NULL
sites	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Nucleotides	NULL
that	NULL
fit	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
are	NULL
shaded	NULL
,	NULL
and	NULL
the	NULL
position	NULL
of	NULL
the	NULL
invariant	NULL
C	NULL
residue	NULL
is	NULL
marked	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

A	NULL
black	NULL
box	NULL
indicates	NULL
the	NULL
gap	NULL
that	NULL
had	NULL
to	NULL
be	NULL
introduced	NULL
into	NULL
site	NULL
2	NULL
for	NULL
optimal	NULL
alignment	NULL
.	NULL

Vor	NULL
.	NULL

12	NULL
,	NULL
1992	NULL
efficient	NULL
promoter	NULL
element	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
a	NULL
B-globin	NULL
reporter	NULL
gene	NULL
in	NULL
transiently	NULL
transfected	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
plasma	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

The	NULL
BSAP	NULL
site	NULL
1	NULL
is	NULL
therefore	NULL
functionally	NULL
similar	NULL
to	NULL
the	NULL
-binding	NULL
site	NULL
of	NULL
the	NULL
H2A-2.2	NULL
gene	NULL
,	NULL
which	NULL
was	NULL
previously	NULL
analyzed	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
in	NULL
B-lymphoid	NULL
cells	NULL
(	NULL
3	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
,	NULL
but	NULL
do	NULL
not	NULL
prove	NULL
,	NULL
that	NULL
the	NULL
high-affinity	NULL
BSAP	NULL
site	NULL
1	NULL
is	NULL
important	NULL
for	NULL
B-cell-specific	NULL
regulation	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
.	NULL

A	NULL
rigorous	NULL
examination	NULL
of	NULL
this	NULL
question	NULL
critically	NULL
depends	NULL
on	NULL
an	NULL
efficient	NULL
expression	NULL
system	NULL
for	NULL
the	NULL
CD19	NULL
gene	NULL
,	NULL
that	NULL
allows	NULL
a	NULL
mutational	NULL
analysis	NULL
of	NULL
BSAP	NULL
site	NULL
1	NULL
in	NULL
its	NULL
normal	NULL
promoter	NULL
context	NULL
.	NULL

We	NULL
have	NULL
fused	NULL
1,300	NULL
or	NULL
300	NULL
bp	NULL
of	NULL
CD19	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
in	NULL
the	NULL
first	NULL
exon	NULL
to	NULL
a	NULL
rabbit	NULL
B-globin	NULL
gene	NULL
which	NULL
either	NULL
lacked	NULL
or	NULL
contained	NULL
a	NULL
downstream	NULL
simian	NULL
virus	NULL
40	NULL
,	NULL
Igk	NULL
,	NULL
or	NULL
IgH	NULL
enhancer	NULL
or	NULL
additional	NULL
multimerized	NULL
-binding	NULL
sites	NULL
.	NULL

With	NULL
all	NULL
of	NULL
these	NULL
constructs	NULL
we	NULL
failed	NULL
,	NULL
however	NULL
,	NULL
to	NULL
detect	NULL
transcription	NULL
from	NULL
the	NULL
human	NULL
CD19	NULL
promoter	NULL
in	NULL
transiently	NULL
transfected	NULL
B	NULL
cells	NULL
(	NULL
36a	NULL
)	NULL
.	NULL

It	NULL
is	NULL
still	NULL
possible	NULL
that	NULL
far	NULL
upstream	NULL
or	NULL
downstream	NULL
sequences	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
which	NULL
are	NULL
absent	NULL
from	NULL
our	NULL
constructs	NULL
are	NULL
absolutely	NULL
required	NULL
for	NULL
expression	NULL
.	NULL

We	NULL
note	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
CD19	NULL
mRNA	NULL
is	NULL
not	NULL
at	NULL
all	NULL
abundant	NULL
in	NULL
expressing	NULL
B-lymphoid	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
suggesting	NULL
low	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
endogenous	NULL
CD19	NULL
promoter	NULL
.	NULL

This	NULL
observation	NULL
combined	NULL
with	NULL
the	NULL
poor	NULL
transfection	NULL
efficiency	NULL
of	NULL
B-cell	NULL
lines	NULL
may	NULL
explain	NULL
our	NULL
failure	NULL
to	NULL
detect	NULL
CD19	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
human	NULL
BSAP	NULL
gene	NULL
has	NULL
recently	NULL
been	NULL
cloned	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
hence	NULL
loss-of-function	NULL
experiments	NULL
eliminating	NULL
BSAP	NULL
activity	NULL
from	NULL
B	NULL
lymphocytes	NULL
can	NULL
now	NULL
be	NULL
used	NULL
as	NULL
alternative	NULL
approaches	NULL
to	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
BSAP	NULL
in	NULL
CD19	NULL
gene	NULL
regulation	NULL
.	NULL

The	NULL
CD19	NULL
gene	NULL
is	NULL
most	NULL
likely	NULL
just	NULL
one	NULL
of	NULL
several	NULL
BSAP	NULL
target	NULL
genes	NULL
in	NULL
B-lymphoid	NULL
cells	NULL
.	NULL

Analysis	NULL
of	NULL
two	NULL
other	NULL
candidate	NULL
genes	NULL
,	NULL
mb-1	NULL
(	NULL
30	NULL
)	NULL
and	NULL
Lyb-2	NULL
(	NULL
24	NULL
)	NULL
,	NULL
demonstrated	NULL
that	NULL
only	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
mb-1	NULL
gene	NULL
strictly	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
BSAP	NULL
activity	NULL
in	NULL
the	NULL
same	NULL
panel	NULL
of	NULL
cell	NULL
lines	NULL
analyzed	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
(	NULL
7a	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
recent	NULL
characterization	NULL
of	NULL
the	NULL
mb-1	NULL
gene	NULL
promoter	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
-binding	NULL
site	NULL
but	NULL
instead	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
.	NULL

This	NULL
DNA-binding	NULL
activity	NULL
,	NULL
termed	NULL
EBF	NULL
,	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
transcription	NULL
of	NULL
the	NULL
mb-1	NULL
gene	NULL
and	NULL
shows	NULL
an	NULL
expression	NULL
profile	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
BSAP	NULL
(	NULL
13	NULL
)	NULL
.	NULL

So	NULL
far	NULL
we	NULL
have	NULL
not	NULL
detected	NULL
any	NULL
EBF-binding	NULL
site	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
sequences	NULL
of	NULL
the	NULL
CD19	NULL
gene	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
special	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
BSAP	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
EBF	NULL
gene	NULL
or	NULL
vice	NULL
versa	NULL
.	NULL

As	NULL
the	NULL
BSAP	NULL
gene	NULL
has	NULL
been	NULL
isolated	NULL
,	NULL
the	NULL
tools	NULL
should	NULL
now	NULL
be	NULL
available	NULL
to	NULL
address	NULL
this	NULL
question	NULL
and	NULL
more	NULL
generally	NULL
to	NULL
study	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
BSAP	NULL
for	NULL
B-cell	NULL
differentiation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
B	NULL
.	NULL

Seed	NULL
for	NULL
providing	NULL
the	NULL
human	NULL
CD19	NULL
cDNA	NULL
clone	NULL
,	NULL
to	NULL
A.-M.	NULL
Frischauf	NULL
for	NULL
supplying	NULL
the	NULL
human	NULL
genomic	NULL
cosmid	NULL
library	NULL
,	NULL
to	NULL
G.	NULL
Schaffner	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
,	NULL
to	NULL
A.	NULL
Schnat-tinger	NULL
and	NULL
R.	NULL
Kurzbauer	NULL
for	NULL
DNA	NULL
sequencing	NULL
,	NULL
to	NULL
H.	NULL
Tkadletz	NULL
for	NULL
artwork	NULL
,	NULL
and	NULL
to	NULL
C.	NULL
Wrighton	NULL
and	NULL
M.	NULL
Zenke	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Institute	NULL
of	NULL
Molecular	NULL
Pathology	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Austrian	NULL
Industrial	NULL
Research	NULL
Promotion	NULL
Fund	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adams	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
Dorfler	NULL
,	NULL
A.	NULL
Aguzzi	NULL
,	NULL
Z.	NULL
Kozmik	NULL
,	NULL
P.	NULL
Urbanek	NULL
,	NULL
I.	NULL
Maurer-Fogy	NULL
,	NULL
and	NULL
M.	NULL
Busslinger	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

1a.Barberis	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Superti-Furga	NULL
,	NULL
and	NULL
M.	NULL
Busslinger	NULL
.	NULL

1987	NULL
.	NULL

Mutually	NULL
exclusive	NULL
interaction	NULL
of	NULL
the	NULL
CCAAT-binding	NULL
factor	NULL
and	NULL
of	NULL
a	NULL
displacement	NULL
protein	NULL
with	NULL
overlapping	NULL
sequences	NULL
of	NULL
a	NULL
histone	NULL
7	NULL
S	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

15a	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

REGULATION	NULL
OF	NULL
THE	NULL
CD19	NULL
GENE	NULL
BY	NULL
BSAP	NULL
2671	NULL
gene	NULL
promoter	NULL
.	NULL

Cell	NULL
50:347-359.	NULL
.	NULL

Barberis	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Superti-Furga	NULL
,	NULL
L.	NULL
Vitelli	NULL
,	NULL
I.	NULL
Kemler	NULL
,	NULL
and	NULL
M.	NULL
Busslinger	NULL
.	NULL

1989	NULL
.	NULL

Developmental	NULL
and	NULL
tissue-specific	NULL
regulation	NULL
of	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
sea	NULL
urchin	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:663-675.	NULL
.	NULL

Barberis	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Widenhorn	NULL
,	NULL
L.	NULL
Vitelli	NULL
,	NULL
and	NULL
M.	NULL
Busslinger	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
novel	NULL
B-cell	NULL
lineage-specific	NULL
transcription	NULL
factor	NULL
present	NULL
at	NULL
early	NULL
but	NULL
not	NULL
late	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:849-859.	NULL
.	NULL

Breathnach	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
Chambon	NULL
.	NULL

1981	NULL
.	NULL

Organization	NULL
and	NULL
expression	NULL
of	NULL
eukaryotic	NULL
split	NULL
genes	NULL
coding	NULL
for	NULL
proteins	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

50:349-383.	NULL
.	NULL

Busslinger	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Moschonas	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1981	NULL
.	NULL

B*	NULL
thalassemia	NULL
:	NULL
aberrant	NULL
splicing	NULL
results	NULL
from	NULL
a	NULL
single	NULL
point	NULL
mutation	NULL
in	NULL
an	NULL
intron	NULL
.	NULL

Cell	NULL
27:289-298.	NULL
.	NULL

Chen	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
.	NULL

1989	NULL
.	NULL

Yeast	NULL
upstream	NULL
activator	NULL
protein	NULL
GCN4	NULL
can	NULL
stimulate	NULL
transcription	NULL
when	NULL
its	NULL
binding	NULL
site	NULL
replaces	NULL
the	NULL
TATA	NULL
element	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:261-268.	NULL
.	NULL

de	NULL
Rie	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
T.	NULL
N.	NULL
M.	NULL
Schumacher	NULL
,	NULL
G.	NULL
M.	NULL
W.	NULL
van	NULL
Schijndel	NULL
,	NULL
R.	NULL
A.	NULL
W.	NULL
van	NULL
Lier	NULL
,	NULL
and	NULL
F.	NULL
Miedema	NULL
.	NULL

1989	NULL
.	NULL

Regulatory	NULL
role	NULL
of	NULL
CD19	NULL
molecules	NULL
in	NULL
B-cell	NULL
activation	NULL
and	NULL
differentiation	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

118:369-381	NULL
.	NULL

.Dorfler	NULL
,	NULL
P.	NULL
Unpublished	NULL
data	NULL
.	NULL

.	NULL

Ehrich	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Craig	NULL
,	NULL
A.	NULL
Poustka	NULL
,	NULL
A.-M.	NULL
Frischauf	NULL
,	NULL
and	NULL
H.	NULL
Lehrach	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
family	NULL
of	NULL
cosmid	NULL
vectors	NULL
with	NULL
the	NULL
multi-copy	NULL
R6K	NULL
replication	NULL
origin	NULL
.	NULL

Gene	NULL
57:229-237.	NULL
.	NULL

Fors	NULL
,	NULL
L.	NULL
,	NULL
R.	NULL
A.	NULL
Saavedra	NULL
,	NULL
and	NULL
L.	NULL
Hood	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
shark	NULL
Po	NULL
promoter	NULL
using	NULL
a	NULL
genomic	NULL
walking	NULL
technique	NULL
based	NULL
on	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:2793-2799	NULL
.	NULL

Frohman	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
M.	NULL
K.	NULL
Dush	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Martin	NULL
.	NULL

1988	NULL
.	NULL

Rapid	NULL
production	NULL
of	NULL
full-length	NULL
cDNAs	NULL
from	NULL
rare	NULL
transcripts	NULL
:	NULL
amplification	NULL
using	NULL
a	NULL
single	NULL
gene-specific	NULL
oligonucleotide	NULL
primer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8998-9002	NULL
.	NULL

Golay	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Crawford	NULL
.	NULL

1987	NULL
.	NULL

Pathways	NULL
of	NULL
human	NULL
B-lymphocyte	NULL
activation	NULL
blocked	NULL
by	NULL
B-cell	NULL
specific	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Immunology	NULL
62:279-284	NULL
.	NULL

Grosschedl	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Birnstiel	NULL
.	NULL

1980	NULL
.	NULL

Identification	NULL
of	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
prelude	NULL
sequences	NULL
of	NULL
an	NULL
H2A	NULL
histone	NULL
gene	NULL
by	NULL
the	NULL
study	NULL
of	NULL
specific	NULL
deletion	NULL
mutants	NULL
in	NULL
vivo	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:1432-1436	NULL
.	NULL

Hagman	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
Travis	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
novel	NULL
lineage-specific	NULL
nuclear	NULL
factor	NULL
regulates	NULL
mb-1	NULL
gene	NULL
transcription	NULL
at	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiaton	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3409-3417	NULL
.	NULL

Hebell	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
M.	NULL
Abearn	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Fearon	NULL
.	NULL

1991	NULL
.	NULL

Suppression	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
by	NULL
a	NULL
soluble	NULL
complement	NULL
receptor	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

Science	NULL
254:102-105	NULL
.	NULL

Hermanson	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
M.	NULL
Briskin	NULL
,	NULL
S.	NULL
Sigman	NULL
,	NULL
and	NULL
R.	NULL
Wali	NULL
.	NULL

1989	NULL
.	NULL

Immunoglobulin	NULL
enhancer	NULL
and	NULL
promoter	NULL
motifs	NULL
5	NULL
'	NULL
of	NULL
the	NULL
B29	NULL
B-cell-specific	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:7341-7345	NULL
.	NULL

Kozmik	NULL
,	NULL
Z	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Kozmik	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
V.	NULL
Paces	NULL
.	NULL

1990	NULL
.	NULL

Multiple	NULL
bandshift	NULL
assay	NULL
:	NULL
rapid	NULL
identification	NULL
and	NULL
cloning	NULL
of	NULL
DNA	NULL
fragments	NULL
containing	NULL
specific	NULL
protein-binding	NULL
sites	NULL
.	NULL

Gene	NULL
90:287-291	NULL
.	NULL

Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
P.	NULL
S.	NULL
Rabinovitch	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
C.	NULL
W.	NULL
Song	NULL
,	NULL
E.	NULL
A.	NULL
Clark	NULL
,	NULL
and	NULL
F.	NULL
M.	NULL
Uckun	NULL
.	NULL

1988	NULL
.	NULL

Antigen-independent	NULL
regulation	NULL
of	NULL
cytoplasmic	NULL
calcium	NULL
in	NULL
B-cells	NULL
with	NULL
a	NULL
12-kDa	NULL
B-cell	NULL
growth	NULL
factor	NULL
and	NULL
anti-CD19	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:1897-1901	NULL
.	NULL

Lee	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
T.	NULL
Kinashi	NULL
,	NULL
K.	NULL
Tohyama	NULL
,	NULL
K.	NULL
Tashiro	NULL
,	NULL
N.	NULL
Funato	NULL
,	NULL
K.	NULL
Hama	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1991	NULL
.	NULL

Different	NULL
stromal	NULL
cell	NULL
lines	NULL
support	NULL
lineage-selective	NULL
differentiation	NULL
of	NULL
the	NULL
multipotential	NULL
bone	NULL
marrow	NULL
stem	NULL
cell	NULL
clone	NULL
LyD9	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:1257-1266	NULL
.	NULL

Maniatis	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
J.	NULL
Sambrook	NULL
.	NULL

1982	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
,	NULL
p.	NULL
312-328	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Matsumoto	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
J.	NULL
Kopicky-Burd	NULL
,	NULL
R.	NULL
H.	NULL
Carter	NULL
,	NULL
D.	NULL
A.	NULL
Tuveson	NULL
,	NULL
T.	NULL
F.	NULL
Tedder	NULL
,	NULL
and	NULL
D.	NULL
F.	NULL
Fearon	NULL
.	NULL

Intersection	NULL
of	NULL
the	NULL
complement	NULL
and	NULL
immune	NULL
systems	NULL
:	NULL
a	NULL
signal	NULL
transduction	NULL
complex	NULL
of	NULL
the	NULL
B	NULL
lymphocyte-containing	NULL
complement	NULL
receptor	NULL
type	NULL
2	NULL
and	NULL
CD19	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:55-64	NULL
.	NULL

Maxam	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1980	NULL
.	NULL

Sequencing	NULL
end-labeled	NULL
2672	NULL
22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

KOZMIK	NULL
ET	NULL
AL	NULL
.	NULL

DNA	NULL
with	NULL
base-specific	NULL
chemical	NULL
cleavages	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65:499-560	NULL
.	NULL

Mueller	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
B.	NULL
Wold	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vivo	NULL
footprinting	NULL
of	NULL
a	NULL
muscle	NULL
specific	NULL
enhancer	NULL
by	NULL
ligation	NULL
mediated	NULL
PCR	NULL
.	NULL

Science	NULL
246:780-786	NULL
.	NULL

Nadler	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
K.	NULL
C.	NULL
Anderson	NULL
,	NULL
G.	NULL
Marti	NULL
,	NULL
M.	NULL
Bates	NULL
,	NULL
E.	NULL
Park	NULL
,	NULL
J.	NULL
F.	NULL
Daley	NULL
,	NULL
and	NULL
S.	NULL
F.	NULL
Schlossman	NULL
.	NULL

1983	NULL
.	NULL

B4	NULL
,	NULL
a	NULL
human	NULL
B	NULL
lymphocyte-associated	NULL
antigen	NULL
expressed	NULL
on	NULL
normal	NULL
,	NULL
mitogen-activated	NULL
,	NULL
and	NULL
malignant	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

131:244-250	NULL
.	NULL

Nakayama	NULL
,	NULL
E.	NULL
,	NULL
I.	NULL
von	NULL
Hoegen	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Parnes	NULL
.	NULL

1989	NULL
.	NULL

Sequence	NULL
of	NULL
the	NULL
Lyb-2	NULL
B-cell	NULL
differentiation	NULL
antigen	NULL
defines	NULL
a	NULL
gene	NULL
super-family	NULL
of	NULL
receptors	NULL
with	NULL
inverted	NULL
membrane	NULL
orientation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1352-1356.	NULL
.	NULL

Palacios	NULL
,	NULL
R.	NULL
,	NULL
H.	NULL
Karasuyama	NULL
,	NULL
and	NULL
A.	NULL
Rolink	NULL
.	NULL

1987	NULL
.	NULL

Ly1*	NULL
Pro-B	NULL
lymphocyte	NULL
clones	NULL
:	NULL
phenotype	NULL
,	NULL
growth	NULL
requirements	NULL
and	NULL
differentiation	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:3687-3693	NULL
.	NULL

Pettersson	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
purine-rich	NULL
DNA	NULL
sequence	NULL
motif	NULL
present	NULL
in	NULL
SV40	NULL
and	NULL
lymphotropic	NULL
papovavirus	NULL
binds	NULL
a	NULL
lymphoid-specific	NULL
factor	NULL
and	NULL
contributes	NULL
to	NULL
enhancer	NULL
activity	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:962-972	NULL
.	NULL

Pezzutto	NULL
,	NULL
A.	NULL
,	NULL
B.	NULL
Dorken	NULL
,	NULL
P.	NULL
S.	NULL
Rabinovitch	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
G.	NULL
Moldenhauer	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Clark	NULL
.	NULL

1987	NULL
.	NULL

CD19	NULL
monoclonal	NULL
antibody	NULL
HD37	NULL
inhibits	NULL
anti-immunoglobulin-induced	NULL
B	NULL
cell	NULL
activation	NULL
and	NULL
proliferation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:2793-2799	NULL
.	NULL

Pugh	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
,	NULL
1990	NULL
.	NULL

Mechanism	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
Sp1	NULL
:	NULL
evidence	NULL
for	NULL
coactivators	NULL
.	NULL

Cell	NULL
61:1187-1197	NULL
.	NULL

Rolink	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
F.	NULL
Melchers	NULL
,	NULL
.	NULL

1991	NULL
.	NULL

Molecular	NULL
and	NULL
cellular	NULL
origins	NULL
of	NULL
B	NULL
lymphocyte	NULL
diversity	NULL
.	NULL

Cell	NULL
66:1081-1094	NULL
.	NULL

Sakaguchi	NULL
,	NULL
N.	NULL
,	NULL
S.-I	NULL
.	NULL

Kashiwamura	NULL
,	NULL
M.	NULL
Kimoto	NULL
,	NULL
P.	NULL
Thalmann	NULL
,	NULL
and	NULL
F.	NULL
Meichers	NULL
.	NULL

1988	NULL
.	NULL

B	NULL
lymphocyte-restricted	NULL
expression	NULL
of	NULL
mb-1	NULL
,	NULL
a	NULL
gene	NULL
with	NULL
CD3-like	NULL
structural	NULL
properties	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:3457-3464	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Mor	NULL
.	NULL

CEL	NULL
.	NULL

BioL	NULL
.	NULL

.	NULL

Sanger	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Nicklen	NULL
,	NULL
and	NULL
A.	NULL
R.	NULL
Coulson	NULL
.	NULL

1977	NULL
.	NULL

DNA	NULL
sequenc-	NULL
ing	NULL
with	NULL
chain-terminating	NULL
inhibitors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
74:5463-5467	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
R.	NULL
Simpson	NULL
,	NULL
and	NULL
W.	NULL
Gilbert	NULL
.	NULL

1988	NULL
.	NULL

E.	NULL
coli	NULL
RNA	NULL
polymerase	NULL
interacts	NULL
homologously	NULL
with	NULL
two	NULL
different	NULL
promoters	NULL
.	NULL

Cell	NULL
20:269-281	NULL
.	NULL

Stamenkovic	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1988	NULL
.	NULL

CD19	NULL
,	NULL
the	NULL
earliest	NULL
differentiation	NULL
antigen	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
lineage	NULL
,	NULL
bears	NULL
three	NULL
extracellular	NULL
immunoglobulin-like	NULL
domains	NULL
and	NULL
an	NULL
Epstein-Barr	NULL
virus-related	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168:1205-1210	NULL
.	NULL

Tedder	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Isaacs	NULL
.	NULL

1989	NULL
.	NULL

Isolation	NULL
of	NULL
cDNAs	NULL
encoding	NULL
the	NULL
CD19	NULL
antigen	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
B	NULL
lympho-cytes	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
immunoglobulin	NULL
superfamily	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:712-717	NULL
.	NULL

Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
W.	NULL
Jaszez	NULL
,	NULL
J.	NULL
L.	NULL
Ambrus	NULL
,	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
K.	NULL
Gajl-Peczalska	NULL
,	NULL
C.	NULL
W.	NULL
Song	NULL
,	NULL
M.	NULL
R.	NULL
Wick	NULL
,	NULL
D.	NULL
E.	NULL
Myers	NULL
,	NULL
K.	NULL
Waddick	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1988	NULL
.	NULL

Detailed	NULL
studies	NULL
on	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
CD19	NULL
surface	NULL
determinant	NULL
by	NULL
using	NULL
B43	NULL
monoclonal	NULL
antibody	NULL
and	NULL
the	NULL
clinical	NULL
potential	NULL
of	NULL
anti-CD19	NULL
immunotoxins	NULL
.	NULL

Blood	NULL
71:13-29	NULL
.	NULL

Vitelli	NULL
,	NULL
L.	NULL
,	NULL
I.	NULL
Kemler	NULL
,	NULL
B.	NULL
Lauber	NULL
,	NULL
M.	NULL
L.	NULL
Birnstiel	NULL
,	NULL
and	NULL
M.	NULL
Busslinger	NULL
.	NULL

1988	NULL
.	NULL

Developmental	NULL
regulation	NULL
of	NULL
micro-injected	NULL
histone	NULL
genes	NULL
in	NULL
sea	NULL
urchin	NULL
embryos	NULL
.	NULL

Dev	NULL
.	NULL

Biol	NULL
.	NULL

127:54-63	NULL
.	NULL

36a	NULL
.	NULL

Wang	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
Dorfler	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

Westin	NULL
,	NULL
G.	NULL
,	NULL
T.	NULL
Gerster	NULL
,	NULL
M.	NULL
M.	NULL
Miller	NULL
,	NULL
G.	NULL
Schaffner	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1987	NULL
.	NULL

OVEC	NULL
,	NULL
a	NULL
versatile	NULL
system	NULL
to	NULL
study	NULL
transcription	NULL
in	NULL
mammalian	NULL
cells	NULL
and	NULL
cell-free	NULL
extracts	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:6787-6798	NULL
.	NULL

Zhou	NULL
,	NULL
L.-J	NULL
.	NULL

,	NULL
D.	NULL
C.	NULL
Ord	NULL
,	NULL
A.	NULL
L.	NULL
Hughes	NULL
,	NULL
and	NULL
T.	NULL
F.	NULL
Tedder	NULL
.	NULL

1991	NULL
.	NULL

Structure	NULL
and	NULL
domain	NULL
organization	NULL
of	NULL
the	NULL
CD19	NULL
antigen	NULL
of	NULL
human	NULL
,	NULL
mouse	NULL
,	NULL
and	NULL
guinea	NULL
pig	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:1424-1432	NULL
.	NULL

